ciprofloxacin has been researched along with Neisseria gonorrhoeae Infection in 373 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "gov database and search terms "gonorrhea/drug therapy"[Mesh] AND "ciprofloxacin"." | 9.12 | A Narrative Review of Clinical Treatment Outcomes of Neisseria gonorrhoeae Infection With Ciprofloxacin by Minimum Inhibitory Concentration and Anatomic Site. ( Chaudry, AE; Klausner, JD, 2021) |
| " During 1996-1997, 105 female sex workers with gonorrhea were prospectively randomized to receive treatment with oral ciprofloxacin, 500 mg, or cefixime, 400 mg, and followed for test of cure." | 9.09 | A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines. ( Aplasca De Los Reyes, MR; Dallabetta, G; Holmes, KK; Klausner, JD; Manalastas, R; Pato-Mesola, V; Tuazon, CU; Whittington, WL; Wi, T, 2001) |
| "A randomized, multicenter, investigator-blind trial was conducted to compare the efficacies of cefuroxime axetil and ciprofloxacin for treatment of patients with uncomplicated gonorrhea caused by penicillinase-producing Neisseria gonorrhoeae (PPNG)." | 9.08 | Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains. ( Collins, JJ; Giguere, GC; Hook, EW; McCormack, WM; Mussari, KL; Rompalo, A; Schwebke, JR; Thorpe, EM, 1996) |
| "This single-blind (investigator) comparative study was designed to determine the efficacy and tolerability of 1 g of azithromycin vs 500 mg of ciprofloxacin both given as a single oral dose in patients with gonorrhea, who were constantly on the move." | 9.08 | Comparative trial of azithromycin and ciprofloxacin in the treatment of gonorrhea. ( Brajac, I; Gruber, F; Grubisic-Greblo, H; Jonjic, A; Lenkovic, M; Stasic, A, 1997) |
| "The aim of this study was to compare the efficacy of single-dose pefloxacin 400 mg and ciprofloxacin 250 mg in the treatment of acute uncomplicated gonococcal urethritis in males." | 9.08 | Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males. ( Chan, RK; Cheong, LL; Goh, CL; Leow, YH; Nadarajah, M, 1995) |
| "Two hundred and seventy-one male patients suffering from uncomplicated gonococcal urethritis were treated in an open randomized study with either 250 mg (121 patients) or 500 mg (150 patients) single oral doses of ciprofloxacin." | 9.06 | Oral ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in men. ( Angelucci, B; De Lalla, F; Rizzardini, G, 1987) |
| "Eighty male patients with gonococcal urethritis were randomly allocated to receive, in an open study, either a single oral 400 mg dose of fleroxacin, or, as standard therapy, a single intramuscular dose of 2." | 9.06 | Fleroxacin versus standard therapy in gonococcal urethritis. ( Ellmén, J; Lassus, A; Renkonen, OV, 1988) |
| " We conducted a prospective, double-blind, randomized clinical trial of 250 mg of ciprofloxacin given orally versus 250 mg of ceftriaxone given intramuscularly for treatment of uncomplicated gonococcal urethritis in adult males." | 9.06 | Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia. ( Brady, W; Bryan, JP; Hira, SK; Krieg, R; Luo, N; Mpoko, G; Mwale, C; Reichart, C; Siwiwaliondo, E; Waters, C, 1990) |
| "Gentamicin has been used for the treatment of gonorrhea in Malawi since 1993." | 8.12 | Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi. ( Bonongwe, N; Chen, JS; Chikaonda, T; Cohen, MS; Golparian, D; Hobbs, MM; Hoffman, IF; Jere, E; Kamtambe, B; Krysiak, R; Massa, C; Mathiya, E; Matoga, M; Ndalama, B; Unemo, M, 2022) |
| "Recent antimicrobial resistance data for Neisseria gonorrhoeae are lacking in Uganda, where, until 2010, ciprofloxacin was the nationally recommended first-line treatment of presumptive gonorrhea." | 7.80 | High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009). ( Bukenya, J; Grosskurth, H; Hughes, P; Lewis, DA; Matovu, G; Vandepitte, J, 2014) |
| "Although ciprofloxacin is one of the recommended drugs of choice for the treatment of gonorrhea, in vitro resistance to this drug has been observed in surveillance studies and case reports from many parts of the world, including Bangladesh." | 7.71 | Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh. ( Alam, A; Albert, MJ; Dutta, DK; Khan, SA; Monira, S; Nahar, S; Nessa, K; Rahman, M; Sultan, Z; Yasmin, L, 2001) |
| "We performed basic and clinical studies on the effects of a new oral antimicrobial agent, fleroxacin (FLRX), a new quinolone derivative in male gonococcal urethritis." | 7.68 | [Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis]. ( Hamaya, O; Miyamura, R; Ono, K; Saito, I; Suzuki, A; Yokozawa, M, 1991) |
| "To study the effectiveness of single-dose pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males." | 7.68 | Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected]. ( Chan, RK; Cheong, LL; Nadarajah, M, 1992) |
| "Ciprofloxacin, a quinolone antibacterial, was evaluated in the treatment of gonococcal, chlamydial, gonococcal and chlamydial, and non-gonococcal non-chlamydial urethritis." | 7.67 | Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. ( Arya, OP; Bartzokas, C; Hart, CA; Hobson, D; Pratt, BC, 1986) |
| "Seven patients (four men, three women) with gonococcal urethritis resistant to spectinomycin treatment were seen in May and June 1989 in the Department of Dermatology in Berlin (West), and strains of Neisseria gonorrhoeae (NG) resistant to spectinomycin were detected, cultured in vitro from these individuals." | 7.67 | [Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain]. ( Adler, M; Hörnle, R; Orfanos, CE; Stadler, R; Wagner, J, 1989) |
| "Cervical gonorrhea was cured in 100% (93 of 93) of the women treated with ciprofloxacin and 99% (83 of 84) receiving ceftriaxone." | 6.67 | Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women. ( Bolan, GA; Echols, R; Haag, JJ; Hook, EW; Jones, RB; Martin, DH; Mroczkowski, TF; Neumann, TM, 1993) |
| "Ciprofloxacin would appear to be a very effective drug in the treatment of urethral gonorrhoea in males." | 6.66 | Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. ( Michel, MF; Mooi, L; Stolz, E; Tegelberg-Stassen, MJ; van der Hoek, JC; van Joost, T; Wagenvoort, JH, 1986) |
| "Treatment with difloxacin was associated with the eradication of C." | 6.66 | Evaluation of difloxacin in the treatment of uncomplicated urethral gonorrhea in men. ( Benes, S; Cummings, M; Draft, K; McCormack, WM; Smith, BL, 1989) |
| " Ciprofloxacin is effective in single dosage against urogenital gonococcal infections, and probably also against rectal and pharyngeal infections." | 6.37 | Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis. ( Oriel, JD, 1986) |
| " gonorrhoeae gyrase subunit A serine 91 codon, we conducted a multisite prospective clinical study of the efficacy of a single oral dose of ciprofloxacin 500 mg in patients with culture-positive gonorrhea." | 5.41 | Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study. ( Asbel, LE; Bolan, RK; Bristow, CC; Goldstein, DA; Klausner, JD; Mena, LA; Morris, SR; Philip, SS; Powell, JA; Shahkolahi, A; Soge, OO; Taylor, SN; Waymer, T; Wierzbicki, MR, 2021) |
| "Ciprofloxacin was less effective than combination treatment against Gardnerella vaginalis." | 5.28 | The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease. ( Heinonen, PK; Laine, S; Miettinen, A; Teisala, K, 1991) |
| "gov database and search terms "gonorrhea/drug therapy"[Mesh] AND "ciprofloxacin"." | 5.12 | A Narrative Review of Clinical Treatment Outcomes of Neisseria gonorrhoeae Infection With Ciprofloxacin by Minimum Inhibitory Concentration and Anatomic Site. ( Chaudry, AE; Klausner, JD, 2021) |
| "The response of male gonococcal urethritis to a single 250 mg dose of ciprofloxacin versus 500 mg was studied." | 5.10 | Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa. ( Coovadia, YM; Moodley, P; Nzimande, G; Pillay, C; Sturm, AW, 2002) |
| " During 1996-1997, 105 female sex workers with gonorrhea were prospectively randomized to receive treatment with oral ciprofloxacin, 500 mg, or cefixime, 400 mg, and followed for test of cure." | 5.09 | A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines. ( Aplasca De Los Reyes, MR; Dallabetta, G; Holmes, KK; Klausner, JD; Manalastas, R; Pato-Mesola, V; Tuazon, CU; Whittington, WL; Wi, T, 2001) |
| "This single-blind (investigator) comparative study was designed to determine the efficacy and tolerability of 1 g of azithromycin vs 500 mg of ciprofloxacin both given as a single oral dose in patients with gonorrhea, who were constantly on the move." | 5.08 | Comparative trial of azithromycin and ciprofloxacin in the treatment of gonorrhea. ( Brajac, I; Gruber, F; Grubisic-Greblo, H; Jonjic, A; Lenkovic, M; Stasic, A, 1997) |
| "The aim of this study was to compare the efficacy of single-dose pefloxacin 400 mg and ciprofloxacin 250 mg in the treatment of acute uncomplicated gonococcal urethritis in males." | 5.08 | Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males. ( Chan, RK; Cheong, LL; Goh, CL; Leow, YH; Nadarajah, M, 1995) |
| "A randomized, multicenter, investigator-blind trial was conducted to compare the efficacies of cefuroxime axetil and ciprofloxacin for treatment of patients with uncomplicated gonorrhea caused by penicillinase-producing Neisseria gonorrhoeae (PPNG)." | 5.08 | Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains. ( Collins, JJ; Giguere, GC; Hook, EW; McCormack, WM; Mussari, KL; Rompalo, A; Schwebke, JR; Thorpe, EM, 1996) |
| "Eighty male patients with gonococcal urethritis were randomly allocated to receive, in an open study, either a single oral 400 mg dose of fleroxacin, or, as standard therapy, a single intramuscular dose of 2." | 5.06 | Fleroxacin versus standard therapy in gonococcal urethritis. ( Ellmén, J; Lassus, A; Renkonen, OV, 1988) |
| "Eighty-six men with uncomplicated gonorrhoea were entered into a study comparing the efficacy of a single oral dose of 250 mg of ciprofloxacin with a single oral dose of ampicillin 2 g and probenecid 1 g for urethral gonorrhoea and a course of ampicillin, 500 mg four times per day for five days in rectal and pharyngeal infection." | 5.06 | Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men. ( McMillan, A; Scott, GR; Young, H, 1987) |
| " We conducted a prospective, double-blind, randomized clinical trial of 250 mg of ciprofloxacin given orally versus 250 mg of ceftriaxone given intramuscularly for treatment of uncomplicated gonococcal urethritis in adult males." | 5.06 | Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia. ( Brady, W; Bryan, JP; Hira, SK; Krieg, R; Luo, N; Mpoko, G; Mwale, C; Reichart, C; Siwiwaliondo, E; Waters, C, 1990) |
| "The results of two therapeutic trials in female patients with uncomplicated urogenital gonorrhoea (A) and in male patients with uncomplicated urethral gonorrhoea (B) treated with either 200 mg and 400 mg enoxacin orally, of one therapeutic trial in male patients with uncomplicated urogenital gonorrhoea treated with either 250 mg or 500 mg ciprofloxacin orally (C) and of one therapeutic trial in male patients with non-gonococcal urethritis (NGU) treated with ciprofloxacin 1 g daily during seven days (D) are presented and compared with the results of other investigators." | 5.06 | Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections. ( Stolz, E; van der Willigen, AH; Wagenvoort, JH, 1987) |
| "Two hundred and seventy-one male patients suffering from uncomplicated gonococcal urethritis were treated in an open randomized study with either 250 mg (121 patients) or 500 mg (150 patients) single oral doses of ciprofloxacin." | 5.06 | Oral ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in men. ( Angelucci, B; De Lalla, F; Rizzardini, G, 1987) |
| "Gentamicin has been used for the treatment of gonorrhea in Malawi since 1993." | 4.12 | Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi. ( Bonongwe, N; Chen, JS; Chikaonda, T; Cohen, MS; Golparian, D; Hobbs, MM; Hoffman, IF; Jere, E; Kamtambe, B; Krysiak, R; Massa, C; Mathiya, E; Matoga, M; Ndalama, B; Unemo, M, 2022) |
| "We investigated the epidemiology of the mutant gyrase A gene, a reliable predictor of ciprofloxacin resistance, in Neisseria gonorrhoeae infections at UCLA Health in Los Angeles, California, USA, during November 1, 2015-August 31, 2016." | 3.85 | Epidemiology of Neisseria gonorrhoeae Gyrase A Genotype, Los Angeles, California, USA. ( Allan-Blitz, LT; Bhatti, AA; Castrejon, M; Hemarajata, P; Humphries, RM; Klausner, JD, 2017) |
| "A mathematical model describing gonorrhea transmission incorporated resistance emergence probabilities and fitness costs associated with resistance based on characteristics of ciprofloxacin (A), azithromycin (B), and ceftriaxone (C)." | 3.85 | Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea. ( Chesson, HW; Gift, TL; Grad, YH; Hsu, K; Salomon, JA; Tuite, AR, 2017) |
| "Oral cefixime or ceftriaxone injections were used as first-line drugs for the treatment of gonorrhea from 2006 to 2013 because gonorrhea isolates had low minimum inhibitory concentrations for these two drugs." | 3.83 | Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013. ( Cheng, CW; Li, LH; Li, SY; Su, CY; Yen, MY, 2016) |
| "Recent antimicrobial resistance data for Neisseria gonorrhoeae are lacking in Uganda, where, until 2010, ciprofloxacin was the nationally recommended first-line treatment of presumptive gonorrhea." | 3.80 | High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009). ( Bukenya, J; Grosskurth, H; Hughes, P; Lewis, DA; Matovu, G; Vandepitte, J, 2014) |
| "Ciprofloxacin resistant gonorrhea (CRG) cultures rose from 1." | 3.75 | Antimicrobial resistance in gonorrhea: the influence of epidemiologic and laboratory surveillance data on treatment guidelines: Alberta, Canada 2001-2007. ( Boyington, C; Lovgren, M; Plitt, S; Read, R; Singh, AE; Sutherland, K; Tilley, P, 2009) |
| "Ciprofloxacin remains highly efficient in Madagascar and Central Africa, ceftriaxone and spectinomycin should be used as the first-line antimicrobial agents in treating gonorrhea in Vietnam." | 3.74 | Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam. ( Bercion, R; Cao, V; Fonkoua, MC; Ratsima, E; Richard, V; Talarmin, A; Van Tri, D, 2008) |
| "Johannesburg and Cape Town have witnessed significant rises in the prevalence of ciprofloxacin-resistant gonorrhoea among men with urethritis." | 3.74 | Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity. ( du Plessis, N; Lewis, DA; Mhlongo, S; Radebe, F; Scott, L; Sello, M; Slabbert, M; van Zijl, A; Wasserman, E, 2008) |
| "Syndromic management guidelines for male urethritis syndrome and female discharge syndrome (nonpregnant) in South Africa advocate the use of ciprofloxacin for potential infection with Neisseria gonorrhoeae." | 3.73 | Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa. ( Ison, CA; Martin, IM; Moodley, P; Pillay, K; Sturm, AW, 2006) |
| " In Bangkok, Thailand, ciprofloxacin has been used to treat gonorrhea since 1987." | 3.71 | Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999. ( Buatiang, A; Kilmarx, PH; Knapp, JS; Neal, SW; Schultz, AJ; Sirivongrangson, P; Trees, DL, 2002) |
| "Ciprofloxacin (500 mg orally, single dose) is one of the recommended therapies for gonorrhea in Canada." | 3.71 | Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada. ( Booth, S; Martin, IE; Ng, LK; Sawatzky, P, 2002) |
| "Neisseria gonorrhoeae infection in the eye and its treatment with ciprofloxacin is presented." | 3.71 | Gonococcal ophthalmia treated with ciprofloxacin. ( O'Mahony, C; Price, LM, 2001) |
| "Although ciprofloxacin is one of the recommended drugs of choice for the treatment of gonorrhea, in vitro resistance to this drug has been observed in surveillance studies and case reports from many parts of the world, including Bangladesh." | 3.71 | Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh. ( Alam, A; Albert, MJ; Dutta, DK; Khan, SA; Monira, S; Nahar, S; Nessa, K; Rahman, M; Sultan, Z; Yasmin, L, 2001) |
| "To describe the emergence of and risk factors for gonococcal urethritis caused by gonococci with decreased susceptibility to ciprofloxacin." | 3.69 | The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. ( Carlyn, CJ; Doyle, LJ; Gordon, SM; Hall, GS; Knapp, CC; Longworth, DL; Washington, JA, 1996) |
| "The susceptibilities of 37 penicillinase-producing strains of Neisseria gonorrhoeae (PPNG), isolated in Hawaii from December 1991 through January 1994, were determined to ciprofloxacin and ofloxacin, fluoroquinolone agents currently recommended by the Centers for Disease Control and Prevention as alternative regimens for the treatment of uncomplicated gonorrhea." | 3.69 | Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii. ( Higa, H; Knapp, JS; Neal, SW; Ohye, R; Parekh, MC; Rice, RJ, 1994) |
| "We performed basic and clinical studies on the effects of a new oral antimicrobial agent, fleroxacin (FLRX), a new quinolone derivative in male gonococcal urethritis." | 3.68 | [Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis]. ( Hamaya, O; Miyamura, R; Ono, K; Saito, I; Suzuki, A; Yokozawa, M, 1991) |
| "To study the effectiveness of single-dose pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males." | 3.68 | Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected]. ( Chan, RK; Cheong, LL; Nadarajah, M, 1992) |
| "Ciprofloxacin, a quinolone antibacterial, was evaluated in the treatment of gonococcal, chlamydial, gonococcal and chlamydial, and non-gonococcal non-chlamydial urethritis." | 3.67 | Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. ( Arya, OP; Bartzokas, C; Hart, CA; Hobson, D; Pratt, BC, 1986) |
| "Seven patients (four men, three women) with gonococcal urethritis resistant to spectinomycin treatment were seen in May and June 1989 in the Department of Dermatology in Berlin (West), and strains of Neisseria gonorrhoeae (NG) resistant to spectinomycin were detected, cultured in vitro from these individuals." | 3.67 | [Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain]. ( Adler, M; Hörnle, R; Orfanos, CE; Stadler, R; Wagner, J, 1989) |
| "A single oral dose of ciprofloxacin 500 mg was used to treat five men with gonococcal urethritis and five men with gonococcal proctitis, and all were cured." | 3.67 | Single dose ciprofloxacin for treating gonococcal infections in men. ( Loo, PS; Oriel, JD; Ridgway, GL, 1985) |
| "Cervical gonorrhea was cured in 100% (93 of 93) of the women treated with ciprofloxacin and 99% (83 of 84) receiving ceftriaxone." | 2.67 | Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women. ( Bolan, GA; Echols, R; Haag, JJ; Hook, EW; Jones, RB; Martin, DH; Mroczkowski, TF; Neumann, TM, 1993) |
| "In a word, both drugs are effective in treating bacterial infections of digestive system, urinary system and respiratory tract." | 2.67 | [Clinical efficacy of ciprofloxacin and ofloxacin]. ( Jiang, SC; Miao, JZ; Wang, XF, 1994) |
| "Gonorrhea, trichomoniasis, chlamydiosis and Ureaplasma infection were detected in 60, 31." | 2.67 | [Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases]. ( Bakalova, LA; Bednova, VN; Bugrov, AV; Kisina, VI; Navolotskaia, TI; Vakhnina, TE, 1992) |
| "Ciprofloxacin would appear to be a very effective drug in the treatment of urethral gonorrhoea in males." | 2.66 | Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. ( Michel, MF; Mooi, L; Stolz, E; Tegelberg-Stassen, MJ; van der Hoek, JC; van Joost, T; Wagenvoort, JH, 1986) |
| "Treatment with difloxacin was associated with the eradication of C." | 2.66 | Evaluation of difloxacin in the treatment of uncomplicated urethral gonorrhea in men. ( Benes, S; Cummings, M; Draft, K; McCormack, WM; Smith, BL, 1989) |
| "Ciprofloxacin was evaluated in chlamydial infections of the urogenital tracts of women treated with a dosage regimen of 500 mg orally twice a day for seven days." | 2.66 | Ciprofloxacin treatment of chlamydial infections of urogenital tracts of women. ( Ahmed-Jushuf, IH; Arya, OP; Hart, CA; Hobson, D; How, SJ; Pratt, BC; Rao, PM; Tait, IA, 1988) |
| "Multidrug-resistant Neisseria gonorrhoeae infections have been declared 1 of the top 3 urgent threats to public health." | 2.55 | Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis. ( Allan-Blitz, LT; Klausner, JD; Wang, X, 2017) |
| " Ciprofloxacin is effective in single dosage against urogenital gonococcal infections, and probably also against rectal and pharyngeal infections." | 2.37 | Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis. ( Oriel, JD, 1986) |
| "Ciprofloxacin has great potential for the oral therapy of infections which have traditionally required parenteral chemotherapy." | 2.37 | Overview of clinical experience with ciprofloxacin. ( Ball, AP, 1986) |
| "We present a case of gonococcal septic arthritis of the right hip diagnosed via synovial fluid cultures." | 1.72 | Right hip gonococcal septic arthritis treatment with successful transition to oral fluoroquinolone. ( Kiamos, A; Sands, M; Torrente, N; Verdecia, J, 2022) |
| "For gentamicin, there was 86." | 1.72 | Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae? ( Barazzetti, FH; Bazzo, ML; de Albuquerque, VCB; de Melo Machado, H; Golfetto, L; Martins, JM; Santos, TMD; Scheffer, MC; Schörner, MA, 2022) |
| "Cefixime resistance was detected in 2." | 1.48 | Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. ( Amato-Gauci, AJ; Cole, MJ; Day, MJ; Jacobsson, S; Spiteri, G; Unemo, M; Woodford, N, 2018) |
| "Ciprofloxacin resistance was seen in < 5% of isolates prior to 2010, but in > 5% thereafter." | 1.48 | High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment? ( Dillon, JR; Horsman, GB; Levett, PN; Thakur, SD, 2018) |
| "The EC 50 of the dose-response curves correlated well with Etest MIC values (Pearson's r = 0." | 1.46 | A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae. ( Althaus, CL; Desilvestro, V; Foerster, S; Hathaway, LJ; Unemo, M, 2017) |
| "Gonorrhea is the second most commonly reported notifiable disease in the United States; 350,062 gonorrhea cases were reported in 2014." | 1.43 | Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. ( Del Rio, C; Harvey, A; Holmes, KK; Hook, EW; Kirkcaldy, RD; Kubin, G; Papp, JR; Pettus, K; Riedel, S; Sanders, T; Sharpe, S; Soge, OO; Torrone, E; Zenilman, J, 2016) |
| "Sexually transmitted infections (STIs), including infections with Neisseria gonorrhoeae (GC), are highly incident in Greenland." | 1.42 | Rapid change in the ciprofloxacin resistance pattern among Neisseria gonorrhoeae strains in Nuuk, Greenland: time to reconsider preventive and treatment strategies. ( Bjorn-Mortensen, K; Jensen, JS; Mulvad, G; Pedersen, ML; Poulsen, P; Rolskov, AS, 2015) |
| "In cases of unilateral purulent conjunctivitis, there should be a high clinical suspicion of GC, early swab for PCR and culture, and knowledge of current CDC-recommended antibiotic guidelines." | 1.42 | Prevalence of gonococcal conjunctivitis in adults and neonates. ( Cassidy, L; Curry, A; Knowles, SJ; McAnena, L, 2015) |
| "Neisseria gonorrhoeae infection is one of the most common causes of urethritis in Poland." | 1.40 | [Resistance to ciprofloxacin of Neisseria gonorrhoeae strains isolated in Poland in 2012-2013]. ( Kujawa, M; Majewski, S; Malejczyk, M; Młynarczyk, G; Młynarczyk-Bonikowska, B, 2014) |
| "Trichomoniasis was detected in 4." | 1.35 | The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa's syndromic management approach be revised? ( Black, V; Lewis, DA; Magooa, P; Myers, M; Pillay, C; Radebe, F, 2008) |
| "Gemifloxacin is a valid therapeutic alternative to treat infections with N." | 1.32 | In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene. ( Aguilar, L; Garcia-Mendez, E; Jiménez De Anta, MT; Marco, F; Mensa, J; Ruiz, J; Sierra, JM; Vila, J, 2003) |
| "Because gonorrhea is the most frequently reported STD there, information on the antimicrobial susceptibility of Neisseria gonorrhoeae will aid in its control." | 1.31 | Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998. ( Dai, X; Su, X; Sun, H; Wang, Q; Ye, S; Yin, Y, 2002) |
| "Gonorrhea is a major cause of pelvic inflammatory disease, often leading to ectopic pregnancy and infertility, and it can facilitate human immunodeficiency virus (HIV) transmission (2)." | 1.31 | Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. ( , 2000) |
| "Ciprofloxacin is a recommended treatment for gonococcal infection in the UK but if resistance continues to increase at the present rate it might not be suitable as a first-line treatment of gonorrhoea for much longer." | 1.31 | Increased ciprofloxacin resistance in gonococci isolated in Scotland. ( Forsyth, A; Moyes, A; Young, H, 2000) |
| "Ciprofloxacin was the most commonly used antibiotic." | 1.31 | Would you get your Gonorrhoea treated in the north of England? ( Elawad, BB; White, C, 2001) |
| "Ciprofloxacin treatment failure rate was 1." | 1.30 | Gonorrhoea treatment failure and ciprofloxacin resistance. ( Chan, RK; Ling, AE; Ng, PP, 1998) |
| "Ciprofloxacin was subjected to a multilaboratory study designed to determine its in vitro susceptibility criteria for Neisseria gonorrhoeae and its quality control parameters for both agar dilution and disk diffusion susceptibility testing for this species." | 1.28 | Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. ( Baker, C; Barry, AL; Fuchs, PC; Murray, PR; Washington, JA, 1991) |
| "Ciprofloxacin was less effective than combination treatment against Gardnerella vaginalis." | 1.28 | The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease. ( Heinonen, PK; Laine, S; Miettinen, A; Teisala, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (6.43) | 18.7374 |
| 1990's | 65 (17.43) | 18.2507 |
| 2000's | 108 (28.95) | 29.6817 |
| 2010's | 106 (28.42) | 24.3611 |
| 2020's | 70 (18.77) | 2.80 |
| Authors | Studies |
|---|---|
| Ilina, EN | 1 |
| Vereshchagin, VA | 1 |
| Borovskaya, AD | 1 |
| Malakhova, MV | 1 |
| Sidorenko, SV | 1 |
| Al-Khafaji, NC | 1 |
| Kubanova, AA | 1 |
| Govorun, VM | 1 |
| Ohnishi, M | 3 |
| Watanabe, Y | 1 |
| Ono, E | 1 |
| Takahashi, C | 1 |
| Oya, H | 1 |
| Kuroki, T | 1 |
| Shimuta, K | 3 |
| Okazaki, N | 1 |
| Nakayama, S | 3 |
| Watanabe, H | 1 |
| Allen, VG | 2 |
| Farrell, DJ | 1 |
| Rebbapragada, A | 1 |
| Tan, J | 1 |
| Tijet, N | 1 |
| Perusini, SJ | 1 |
| Towns, L | 1 |
| Lo, S | 1 |
| Low, DE | 1 |
| Melano, RG | 2 |
| Quilter, LAS | 1 |
| St Cyr, SB | 2 |
| Hong, J | 1 |
| Asbel, L | 1 |
| Bautista, I | 1 |
| Carter, B | 1 |
| Casimir, Y | 1 |
| Denny, M | 1 |
| Ervin, M | 1 |
| Gomez, R | 1 |
| Harvey, A | 2 |
| Holderman, JL | 1 |
| Johnson, K | 1 |
| Kohn, RP | 1 |
| Learner, ER | 1 |
| Mauk, K | 1 |
| Menza, T | 1 |
| Mettenbrink, C | 1 |
| Nettleton, WD | 1 |
| Nicosia, KR | 1 |
| Pham, CD | 3 |
| Ried, C | 1 |
| Schlanger, K | 1 |
| Schneider, A | 1 |
| Soge, OO | 6 |
| Tabidze, I | 1 |
| Taylor, SN | 2 |
| Tilghman, W | 1 |
| Toler, C | 1 |
| Weinstock, H | 3 |
| Torrone, EA | 1 |
| Cameron-McDermott, SM | 1 |
| Barrow, GJ | 1 |
| Webster, AM | 1 |
| De La Haye, CO | 1 |
| Wood, DHE | 1 |
| Lewis, VM | 1 |
| Nicholson, A | 1 |
| Reynolds-Campbell, GY | 1 |
| Thoms-Rodriguez, CA | 1 |
| Roye-Green, KJ | 1 |
| Otto-Stewart, N | 1 |
| Miller, ZN | 1 |
| Tomlinson, JA | 1 |
| Skyers, N | 1 |
| Unemo, M | 30 |
| Anzinger, JJ | 1 |
| Matoga, M | 2 |
| Chen, JS | 2 |
| Krysiak, R | 2 |
| Ndalama, B | 1 |
| Massa, C | 1 |
| Bonongwe, N | 1 |
| Mathiya, E | 1 |
| Kamtambe, B | 1 |
| Jere, E | 1 |
| Chikaonda, T | 1 |
| Golparian, D | 6 |
| Cohen, MS | 1 |
| Hobbs, MM | 1 |
| Hoffman, IF | 1 |
| Lin, X | 1 |
| Chen, W | 1 |
| Xie, Q | 1 |
| Yu, Y | 2 |
| Liao, Y | 1 |
| Feng, Z | 1 |
| Qin, X | 1 |
| Wu, X | 1 |
| Tang, S | 1 |
| Zheng, H | 1 |
| Pilkie, D | 1 |
| Gratrix, J | 2 |
| Sawatzky, P | 3 |
| Martin, I | 13 |
| Singh, A | 1 |
| Prasad, E | 1 |
| Naidu, P | 3 |
| Mulvey, M | 1 |
| Wong, T | 5 |
| Smyczek, PA | 1 |
| Cassu-Corsi, D | 1 |
| Santos, FF | 1 |
| Cayô, R | 1 |
| Martins, WMBS | 1 |
| Nodari, CS | 1 |
| Almeida, LGP | 1 |
| Martins, RA | 1 |
| Carvalho da Silva, RJ | 1 |
| Vasconcelos, ATR | 1 |
| Pignatari, ACC | 1 |
| Gales, AC | 1 |
| Vanbaelen, T | 1 |
| Van Dijck, C | 3 |
| Laumen, J | 1 |
| Gonzalez, N | 3 |
| De Baetselier, I | 3 |
| Manoharan-Basil, SS | 1 |
| De Block, T | 3 |
| Kenyon, C | 3 |
| Al-Maslamani, M | 1 |
| Elmagboul, EBI | 1 |
| Puthiyottil, A | 1 |
| Chemaitelly, H | 1 |
| Varghese, MK | 1 |
| Al Romaihi, HE | 1 |
| Al-Thani, MH | 1 |
| Al Khal, A | 1 |
| Abu-Raddad, LJ | 1 |
| Liu, H | 1 |
| Tang, K | 1 |
| Schmerer, M | 1 |
| Kersh, EN | 2 |
| Raphael, BH | 1 |
| Martins, JM | 1 |
| Scheffer, MC | 1 |
| de Melo Machado, H | 1 |
| Schörner, MA | 1 |
| Golfetto, L | 2 |
| Santos, TMD | 1 |
| Barazzetti, FH | 1 |
| de Albuquerque, VCB | 1 |
| Bazzo, ML | 2 |
| Lahra, MM | 17 |
| Escher, M | 1 |
| Eremin, S | 1 |
| Cole, MJ | 13 |
| Galarza, P | 5 |
| Ndowa, F | 2 |
| Dillon, JR | 5 |
| Galas, M | 1 |
| Ramon-Pardo, P | 1 |
| Wi, T | 7 |
| Day, MJ | 2 |
| Jacobsson, S | 11 |
| Spiteri, G | 7 |
| Kulishev, C | 1 |
| Sajedi, N | 1 |
| Woodford, N | 5 |
| Blumel, B | 1 |
| van der Werf, MJ | 1 |
| Amato-Gauci, AJ | 4 |
| Allan-Blitz, LT | 10 |
| Adamson, PC | 2 |
| Klausner, JD | 20 |
| Galicia, P | 1 |
| Linares, M | 1 |
| Miguel-Benito, A | 1 |
| Pérez García, F | 1 |
| Górgolas, M | 1 |
| Ramos-Rincón, JM | 1 |
| Cuadros, J | 1 |
| Jorge-Berrocal, A | 1 |
| Vargas-Herrera, N | 1 |
| Benites, C | 1 |
| Salazar-Quispe, F | 1 |
| Mayta-Barrios, M | 1 |
| Barrios-Cárdenas, YJ | 1 |
| Yagui, M | 1 |
| Ayfan, AKS | 1 |
| Macdonald, J | 1 |
| Irwin, AD | 1 |
| Zowawi, HM | 1 |
| Forde, BM | 1 |
| Paterson, DL | 1 |
| Whiley, DM | 8 |
| Nokchan, N | 1 |
| Wongsurawat, T | 1 |
| Jenjaroenpun, P | 1 |
| Nitayanon, P | 1 |
| Tribuddharat, C | 1 |
| Sarenje, KL | 1 |
| Ngalamika, O | 1 |
| Maimbolwa, MC | 1 |
| Siame, A | 1 |
| Munsaka, SM | 1 |
| Kwenda, G | 1 |
| Hogan, TR | 5 |
| Armstrong, BH | 2 |
| Visser, M | 1 |
| Götz, HM | 1 |
| van Dam, AP | 2 |
| van Benthem, BH | 1 |
| Kiamos, A | 1 |
| Torrente, N | 1 |
| Sands, M | 1 |
| Verdecia, J | 1 |
| Goytia, M | 1 |
| Wadsworth, CB | 1 |
| Sánchez, NO | 1 |
| Pérez, NF | 1 |
| Martínez, SB | 1 |
| Nielsen, KE | 1 |
| Kreisel, KM | 1 |
| Rubin, DHF | 2 |
| Ma, KC | 1 |
| Westervelt, KA | 1 |
| Hullahalli, K | 1 |
| Waldor, MK | 1 |
| Grad, YH | 7 |
| Qquellon, J | 1 |
| Vargas, SK | 1 |
| Eguiluz, M | 1 |
| Vasquez, F | 1 |
| Durand, D | 1 |
| Konda, KA | 1 |
| Ochoa, TJ | 1 |
| Caceres, CF | 1 |
| Bristow, CC | 2 |
| Mortimer, TD | 3 |
| Morris, S | 1 |
| Wakatake, E | 1 |
| Pascual, R | 1 |
| Murphy, SM | 2 |
| Fryling, KE | 1 |
| Dillon, JA | 7 |
| Parmar, NR | 1 |
| Le, HHL | 1 |
| Van Le, H | 1 |
| Ovalles Ureña, RM | 1 |
| Mitchev, N | 2 |
| Mlisana, K | 1 |
| Dickson, SP | 1 |
| Elise Laumen, JG | 2 |
| Abdellati, S | 2 |
| S Manoharan-Basil, S | 2 |
| Rubin, DH | 1 |
| Riou, J | 1 |
| Althaus, CL | 2 |
| Allen, H | 1 |
| Heijne, JCM | 1 |
| Low, N | 1 |
| Tjandra, KC | 1 |
| Ram-Mohan, N | 1 |
| Abe, R | 1 |
| Wang, TH | 1 |
| Yang, S | 3 |
| Herrero, M | 1 |
| Broner, S | 1 |
| Cruells, A | 1 |
| Esteve, S | 1 |
| Ferré, L | 1 |
| Mendioroz, J | 1 |
| Jané, M | 1 |
| Ciruela, P | 1 |
| Tickner, JA | 1 |
| Trembizki, E | 6 |
| Liang, J | 1 |
| Li, X | 1 |
| Bi, C | 2 |
| Liu, W | 1 |
| Zhang, X | 2 |
| Cao, W | 2 |
| Bell, SFE | 1 |
| Ware, RS | 1 |
| Lewis, DA | 10 |
| Kakooza, F | 2 |
| Maseko, V | 1 |
| Lamorde, M | 2 |
| Manabe, YC | 3 |
| Kularatne, R | 1 |
| Godreuil, S | 1 |
| Hoffman, I | 1 |
| Bercot, B | 2 |
| Vestberg, N | 1 |
| Bhattarai, KH | 1 |
| Fang, H | 1 |
| Roytrakul, S | 1 |
| Sangprasert, P | 1 |
| Jaresitthikunchai, J | 1 |
| Phaonakrop, N | 1 |
| Arpornsuwan, T | 1 |
| Blouin, K | 1 |
| Lefebvre, B | 4 |
| Trudelle, A | 1 |
| Defay, F | 1 |
| Perrault Sullivan, G | 1 |
| Ezin Aloffan, LND | 1 |
| Labbé, AC | 3 |
| Allan-Blitz, L-T | 1 |
| Shah, P | 1 |
| Adams, G | 1 |
| Branda, JA | 1 |
| Goldstein, R | 1 |
| Sabeti, PC | 1 |
| Lemieux, JE | 1 |
| Van Hal, S | 1 |
| Peters, RPH | 1 |
| Jung, H | 1 |
| Mdingi, MM | 1 |
| Gigi, R | 1 |
| Shroufi, A | 1 |
| Martinez, FP | 1 |
| Bamford, C | 1 |
| Ma, A | 1 |
| Ferrato, C | 1 |
| Smyczek, P | 1 |
| Dingle, TC | 1 |
| Zienkiewicz, AK | 1 |
| Verschueren van Rees, N | 1 |
| Homer, M | 1 |
| Ong, JJ | 1 |
| Christensen, H | 2 |
| Hill, D | 1 |
| Looker, KJ | 1 |
| Horner, P | 1 |
| Hughes, G | 2 |
| Turner, KME | 2 |
| Wynn, A | 2 |
| Młynarczyk-Bonikowska, B | 2 |
| Majewska, A | 1 |
| Malejczyk, M | 3 |
| Młynarczyk, G | 2 |
| Majewski, S | 3 |
| Berntsen, S | 1 |
| Mulvad, G | 2 |
| Jensen, JS | 4 |
| Poulsen, P | 5 |
| Hansen, HL | 1 |
| Pedersen, ML | 4 |
| Quinten, C | 1 |
| Day, M | 4 |
| de Korne-Elenbaas, J | 1 |
| Pol, A | 1 |
| Vet, J | 1 |
| Dierdorp, M | 1 |
| Bruisten, SM | 1 |
| Enriquez, RP | 5 |
| George, CRR | 3 |
| Crucitti, T | 1 |
| Belinga, S | 1 |
| Fonkoua, MC | 2 |
| Abanda, M | 1 |
| Mbanzouen, W | 1 |
| Sokeng, E | 1 |
| Nzouankeu, A | 1 |
| Workneh, M | 1 |
| Hamill, MM | 1 |
| Mande, E | 1 |
| Wagner, J | 2 |
| Mbabazi, O | 2 |
| Mugasha, R | 1 |
| Kajumbula, H | 1 |
| Walwema, R | 1 |
| Zenilman, J | 2 |
| Musinguzi, P | 1 |
| Kyambadde, P | 1 |
| Shoushtari, M | 2 |
| Selb, R | 1 |
| Jansen, K | 2 |
| Eckardt, M | 1 |
| Tamminga, T | 1 |
| Dudareva, S | 2 |
| Gassowski, M | 1 |
| Graeber, I | 1 |
| Guhl, E | 2 |
| Heuer, D | 1 |
| Buder, S | 2 |
| Mason, C | 1 |
| Khan, N | 1 |
| Meo, P | 1 |
| Shahkolahi, A | 3 |
| Waymer, T | 1 |
| Bolan, RK | 1 |
| Philip, SS | 2 |
| Asbel, LE | 1 |
| Mena, LA | 1 |
| Goldstein, DA | 1 |
| Powell, JA | 1 |
| Wierzbicki, MR | 1 |
| Morris, SR | 1 |
| Peterson, SW | 3 |
| Demczuk, W | 4 |
| Barairo, N | 1 |
| Allen, V | 2 |
| Hoang, L | 3 |
| Hatchette, TF | 1 |
| Alexander, D | 1 |
| Tomas, K | 1 |
| Trubnikov, M | 1 |
| Mulvey, MR | 4 |
| Abbasi, J | 1 |
| Hadad, R | 1 |
| Ebeyan, S | 2 |
| Tan, LY | 3 |
| Erskine, S | 2 |
| Whiley, D | 2 |
| Miller, S | 1 |
| Degener, T | 1 |
| Patel, P | 1 |
| Chaudry, AE | 1 |
| Cotton, S | 1 |
| McHugh, MP | 1 |
| Etherson, M | 1 |
| Shepherd, J | 1 |
| Templeton, KE | 1 |
| Ahlstrand, J | 1 |
| Sánchez-Busó, L | 2 |
| Aanensen, D | 1 |
| Salmerón, P | 1 |
| Viñado, B | 1 |
| Arando, M | 1 |
| Alcoceba, E | 1 |
| Romero, B | 1 |
| Menéndez, B | 1 |
| Bernal, S | 1 |
| Idigoras, P | 1 |
| Colomina, J | 1 |
| Martin-Saco, G | 1 |
| Leal-Negredo, Á | 1 |
| Torreblanca, A | 1 |
| Martínez, O | 1 |
| Serra-Pladevall, J | 1 |
| Lee, DYJ | 1 |
| Ashcroft, MM | 1 |
| Chow, EPF | 1 |
| Sait, M | 1 |
| De Petra, V | 2 |
| Tschaepe, M | 1 |
| Lange, S | 1 |
| Taiaroa, G | 1 |
| Bradshaw, CS | 1 |
| Fairley, CK | 2 |
| Howden, BP | 1 |
| Chen, MY | 1 |
| Pasricha, S | 1 |
| Williamson, DA | 1 |
| Findlater, L | 1 |
| Mohammed, H | 1 |
| Gobin, M | 1 |
| Fifer, H | 3 |
| Ross, J | 1 |
| Geffen Obregon, O | 1 |
| Kularatne, RS | 1 |
| Kufa, T | 1 |
| Gumede, L | 2 |
| Maseko, DV | 1 |
| Egli, K | 1 |
| Roditscheff, A | 1 |
| Flückiger, U | 1 |
| Risch, M | 1 |
| Risch, L | 1 |
| Bodmer, T | 1 |
| Allen, GP | 1 |
| Deao, KM | 1 |
| Hill, SA | 1 |
| Schipelliti, SM | 1 |
| Tran, T | 1 |
| Eyre, DW | 1 |
| De Silva, D | 1 |
| Cole, K | 1 |
| Peters, J | 1 |
| Crook, DW | 1 |
| Walker, AS | 1 |
| Peto, TEA | 1 |
| Paul, J | 1 |
| Wang, X | 1 |
| Foerster, S | 2 |
| Desilvestro, V | 1 |
| Hathaway, LJ | 1 |
| Latif, AS | 2 |
| Gwanzura, L | 2 |
| Machiha, A | 1 |
| Tarupiwa, A | 1 |
| Gudza-Mugabe, M | 1 |
| Shukusho, FD | 1 |
| Chakanyuka Musanhu, C | 1 |
| Jiang, FX | 1 |
| Lan, Q | 1 |
| Le, WJ | 2 |
| Su, XH | 2 |
| Katz, AR | 2 |
| Komeya, AY | 1 |
| Kirkcaldy, RD | 6 |
| Whelen, AC | 1 |
| Papp, JR | 3 |
| Wasserman, GM | 1 |
| O'Connor, NP | 1 |
| O'Brien, PS | 1 |
| Sato, DT | 1 |
| Maningas, EV | 1 |
| Kunimoto, GY | 1 |
| Tomas, JE | 1 |
| Turner, KM | 1 |
| Adams, EJ | 1 |
| McAdams, D | 1 |
| McDonnell, A | 1 |
| Zhao, L | 1 |
| Liu, A | 1 |
| Li, R | 1 |
| Zhao, S | 1 |
| Perera, SR | 1 |
| Khan, NH | 1 |
| Taheri, A | 1 |
| Parti, RP | 1 |
| Levett, PN | 4 |
| Horsman, GB | 4 |
| Kusalik, A | 1 |
| Buckley, C | 3 |
| Freeman, K | 1 |
| Baird, RW | 1 |
| Beaman, M | 1 |
| Chen, M | 2 |
| Donovan, B | 3 |
| Kundu, RL | 2 |
| Guy, R | 3 |
| Hogan, T | 1 |
| Kaldor, JM | 2 |
| Karimi, M | 1 |
| Limnios, A | 1 |
| Regan, DG | 2 |
| Ryder, N | 1 |
| Su, JY | 1 |
| Ward, J | 1 |
| Bhatti, AA | 1 |
| Castrejon, M | 1 |
| Humphries, RM | 7 |
| Hemarajata, P | 7 |
| Seib, KL | 1 |
| Jen, FE | 1 |
| Scott, AL | 1 |
| Tan, A | 1 |
| Jennings, MP | 1 |
| Tripodo, F | 3 |
| Tuite, AR | 1 |
| Gift, TL | 2 |
| Chesson, HW | 2 |
| Hsu, K | 1 |
| Salomon, JA | 1 |
| Affolabi, D | 1 |
| Goma, E | 1 |
| Sogbo, F | 1 |
| Ahotin, G | 1 |
| Orekan, J | 1 |
| Massou, F | 1 |
| Behanzin, L | 1 |
| Guédou, F | 1 |
| Alary, M | 2 |
| Thakur, SD | 5 |
| Sood, S | 1 |
| Agarwal, M | 1 |
| Bala, M | 6 |
| Mahajan, N | 1 |
| Singh, R | 1 |
| Kapil, A | 1 |
| Sreenivas, V | 1 |
| Ram, RJ | 1 |
| Kar, HK | 1 |
| Sharma, VK | 1 |
| Phouangsouvanh, S | 1 |
| Mayxay, M | 1 |
| Keoluangkhot, V | 1 |
| Vongsouvath, M | 1 |
| Davong, V | 1 |
| Dance, DAB | 1 |
| Segura, ER | 1 |
| Wylie, J | 2 |
| Haldane, D | 2 |
| Loenenbach, A | 1 |
| Nikisins, S | 1 |
| Sailer, A | 1 |
| Kohl, PK | 1 |
| Bremer, V | 1 |
| Kimble, M | 1 |
| Elias, S | 1 |
| Gaspar, PC | 1 |
| Pires, AF | 1 |
| Ramos, MC | 1 |
| Franchini, M | 1 |
| Ferreira, WA | 2 |
| Benzaken, AS | 2 |
| Carvallo, MET | 1 |
| Araya Rodriguez, P | 1 |
| Cruz, OMS | 1 |
| Hernandez, AL | 3 |
| Martinez, MF | 1 |
| Borthagaray, G | 3 |
| Payares, D | 3 |
| Moreno, JE | 1 |
| Chiappe, M | 1 |
| Corredor, AH | 2 |
| Harris, SR | 1 |
| Goater, R | 1 |
| Abudahab, K | 1 |
| Yeats, CA | 1 |
| Borrego, MJ | 1 |
| Crowley, B | 1 |
| Stefanelli, P | 2 |
| Abad, R | 1 |
| Aanensen, DM | 1 |
| Hardick, J | 1 |
| Crowell, TA | 1 |
| Lombardi, K | 1 |
| Akintunde, A | 1 |
| Odeyemi, S | 1 |
| Ivo, A | 1 |
| Eluwa, G | 1 |
| Njab, J | 1 |
| Baral, SD | 1 |
| Nowak, RG | 1 |
| Quinn, TC | 1 |
| Barbian, K | 1 |
| Anzick, S | 1 |
| Adebajo, S | 1 |
| Charurat, ME | 1 |
| Ake, J | 1 |
| Gaydos, CA | 1 |
| Jönsson, A | 1 |
| Ellis, OL | 2 |
| Bolan, R | 1 |
| McGrath, M | 1 |
| Tayimetha, CY | 1 |
| Mabonga, E | 1 |
| Parkes-Ratanshi, R | 1 |
| Riedel, S | 2 |
| Nabweyambo, S | 1 |
| Taylor, C | 1 |
| Gaydos, C | 1 |
| Yéo, A | 1 |
| Kouamé-Blavo, B | 1 |
| Kouamé, CE | 1 |
| Ouattara, A | 1 |
| Yao, AC | 1 |
| Gbedé, BD | 1 |
| Bazan, F | 1 |
| Faye-Ketté, H | 1 |
| Dosso, M | 1 |
| Jacobson, RK | 1 |
| Notaro, MJ | 1 |
| Carr, GJ | 1 |
| Ellis, O | 1 |
| Masinde, G | 1 |
| Buchs, K | 1 |
| Windsor, M | 1 |
| Bordin, A | 1 |
| Mhango, L | 1 |
| Mokany, E | 2 |
| Purriños-Hermida, MJ | 1 |
| Losada Castillo, I | 1 |
| Pousa Ortega, Á | 1 |
| Paz Montero, Ó | 1 |
| Amado Fernández, E | 1 |
| Malvar Pintos, A | 1 |
| Hanrahan, JK | 1 |
| Mitchell, H | 1 |
| Lau, CL | 1 |
| Wee, R | 1 |
| Truong, A | 1 |
| Ebeyan, SM | 1 |
| Flynn, R | 1 |
| Rebick, GW | 1 |
| Gold, WL | 1 |
| Zaidi, A | 1 |
| Hook, EW | 8 |
| Holmes, KK | 6 |
| Holmes, KH | 1 |
| Soge, O | 1 |
| del Rio, C | 3 |
| Hall, G | 2 |
| Papp, J | 1 |
| Bolan, G | 2 |
| Weinstock, HS | 3 |
| Magooa, MP | 1 |
| Müller, EE | 1 |
| Koedijk, FD | 2 |
| van den Broek, I | 1 |
| Stirbu-Wagner, I | 1 |
| van Bergen, JE | 1 |
| Clausen-Dichow, P | 1 |
| Nyborg, H | 1 |
| Morita-Ishihara, T | 2 |
| Dorin, M | 1 |
| Kawahata, T | 2 |
| Kovari, H | 1 |
| de Melo Oliveira, MD | 1 |
| Hauser, P | 1 |
| Läuchli, S | 1 |
| Meyer, J | 1 |
| Weber, R | 1 |
| Zbinden, R | 1 |
| Mlynarczyk-Bonikowska, B | 1 |
| Serwin, AB | 1 |
| Walter de Walthoffen, S | 1 |
| Koper, M | 1 |
| Domeika, M | 1 |
| Endimiani, A | 1 |
| Guilarte, YN | 1 |
| Tinguely, R | 1 |
| Hirzberger, L | 1 |
| Selvini, S | 1 |
| Lupo, A | 1 |
| Hauser, C | 1 |
| Furrer, H | 1 |
| Vandepitte, J | 1 |
| Hughes, P | 1 |
| Matovu, G | 1 |
| Bukenya, J | 1 |
| Grosskurth, H | 1 |
| Owusu-Edusei, K | 1 |
| Furubayashi, K | 1 |
| Kubanova, A | 1 |
| Kubanov, A | 2 |
| Frigo, N | 1 |
| Solomka, V | 2 |
| Semina, V | 1 |
| Vorobyev, D | 2 |
| Khairullin, R | 1 |
| Zhu, BY | 1 |
| Yu, RX | 2 |
| Yin, Y | 3 |
| Chen, X | 1 |
| Li, W | 2 |
| Dai, XQ | 3 |
| Liang, M | 1 |
| Gan, Q | 1 |
| Huang, YJ | 1 |
| Wei, JP | 1 |
| Brunner, A | 2 |
| Nemes-Nikodem, E | 2 |
| Mihalik, N | 1 |
| Marschalko, M | 2 |
| Karpati, S | 2 |
| Ostorhazi, E | 2 |
| Kujawa, M | 1 |
| Chisholm, SA | 3 |
| Hoffmann, S | 2 |
| Ison, CA | 8 |
| Van de Laar, M | 1 |
| Cheng, CW | 1 |
| Li, LH | 1 |
| Su, CY | 1 |
| Li, SY | 1 |
| Yen, MY | 1 |
| Cao, WL | 2 |
| Liang, JY | 1 |
| Li, XD | 1 |
| Yang, RD | 1 |
| Liang, YH | 1 |
| Li, P | 1 |
| Zhong, DQ | 1 |
| Ye, XD | 1 |
| Zhang, XB | 1 |
| Town, K | 1 |
| Lowndes, CM | 2 |
| Obi, C | 1 |
| Chisholm, S | 2 |
| Gu, WM | 1 |
| Chen, Y | 1 |
| Yang, Y | 1 |
| Wu, L | 1 |
| Hu, WZ | 1 |
| Jin, YL | 1 |
| Espinosa, K | 1 |
| Park, JA | 1 |
| Gerrity, JJ | 1 |
| Buono, S | 1 |
| Shearer, A | 1 |
| Dick, C | 1 |
| Mak, ML | 1 |
| Teramoto, K | 1 |
| Pandori, M | 1 |
| Hess, D | 1 |
| Singh, V | 1 |
| Bhargava, A | 1 |
| Ramesh, V | 1 |
| McAnena, L | 1 |
| Knowles, SJ | 1 |
| Curry, A | 1 |
| Cassidy, L | 1 |
| Rolskov, AS | 1 |
| Bjorn-Mortensen, K | 1 |
| Kidd, S | 1 |
| Moore, PC | 1 |
| Wiesenfeld, HC | 1 |
| Kerndt, PR | 1 |
| Venkatasubramanian, L | 1 |
| Ghanem, KG | 1 |
| Bharat, A | 1 |
| Tyrrell, G | 1 |
| Horsman, G | 1 |
| Garceau, R | 1 |
| Wang, BX | 1 |
| Liu, YR | 1 |
| Wan, C | 1 |
| Li, S | 1 |
| Alm, RA | 1 |
| Mueller, JP | 1 |
| Rice, PA | 1 |
| Wilson, J | 1 |
| Alexander, S | 2 |
| Al-Shahib, A | 1 |
| Schaefer, U | 1 |
| Lythgow, K | 1 |
| Ghathian, K | 1 |
| Calum, H | 1 |
| Gyssens, IC | 1 |
| Frimodt-Møller, N | 1 |
| Pond, MJ | 1 |
| Hall, CL | 1 |
| Miari, VF | 1 |
| Cole, M | 1 |
| Laing, KG | 1 |
| Jagatia, H | 1 |
| Harding-Esch, E | 1 |
| Monahan, IM | 1 |
| Planche, T | 1 |
| Hinds, J | 1 |
| Butcher, PD | 1 |
| Sadiq, ST | 1 |
| Lee, H | 1 |
| Kim, H | 1 |
| Kim, HJ | 1 |
| Suh, YH | 1 |
| Yong, D | 2 |
| Jeong, SH | 1 |
| Lee, K | 2 |
| Chong, Y | 2 |
| Kubin, G | 1 |
| Pettus, K | 1 |
| Sanders, T | 1 |
| Sharpe, S | 1 |
| Torrone, E | 1 |
| Chestkov, A | 1 |
| Leinsoo, A | 1 |
| Shaskolskiy, B | 1 |
| Dementieva, E | 1 |
| Plakhova, X | 1 |
| Gryadunov, D | 1 |
| Deryabin, D | 1 |
| Berthelsen, L | 1 |
| Nørgaard, C | 2 |
| Regnath, T | 2 |
| Mertes, T | 1 |
| Ignatius, R | 1 |
| Jeney, C | 1 |
| Szabo, D | 1 |
| Bhatti, A | 1 |
| Pandori, MW | 1 |
| Siedner, MJ | 1 |
| Araya, P | 1 |
| Sanabria Cruz, OM | 1 |
| Carvallo, ME | 2 |
| Chen, SC | 1 |
| Han, Y | 1 |
| Zheng, BJ | 1 |
| Zhang, GY | 1 |
| Chen, XS | 2 |
| Scott, L | 1 |
| Slabbert, M | 1 |
| Mhlongo, S | 1 |
| van Zijl, A | 1 |
| Sello, M | 1 |
| du Plessis, N | 1 |
| Radebe, F | 2 |
| Wasserman, E | 1 |
| Cao, V | 1 |
| Ratsima, E | 1 |
| Van Tri, D | 1 |
| Bercion, R | 1 |
| Richard, V | 1 |
| Talarmin, A | 1 |
| Martín, MC | 1 |
| Pérez, F | 1 |
| Moreno, A | 1 |
| Moral, A | 1 |
| Alvarez, MA | 1 |
| Méndez, FJ | 1 |
| Vázquez, F | 1 |
| García, S | 1 |
| Casco, R | 1 |
| Perazzi, B | 1 |
| De Mier, C | 1 |
| Vay, C | 1 |
| Famiglietti, A | 1 |
| van Veen, MG | 1 |
| de Neeling, AJ | 1 |
| Linde, GB | 1 |
| van der Sande, MA | 1 |
| Plitt, S | 1 |
| Boyington, C | 1 |
| Sutherland, K | 1 |
| Lovgren, M | 1 |
| Tilley, P | 1 |
| Read, R | 1 |
| Singh, AE | 1 |
| Farhi, D | 1 |
| Hotz, C | 1 |
| Poupet, H | 1 |
| Gerhardt, P | 1 |
| Morand, P | 1 |
| Poyart, C | 1 |
| Sednaoui, P | 2 |
| Avril, MF | 1 |
| Dupin, N | 1 |
| Herchline, TE | 1 |
| Inkrott, BP | 1 |
| Dan, M | 4 |
| Mor, Z | 1 |
| Gottliev, S | 1 |
| Sheinberg, B | 2 |
| Shohat, T | 1 |
| Starnino, S | 2 |
| Dal Conte, I | 1 |
| Matteelli, A | 1 |
| Galluppi, E | 1 |
| Cusini, M | 1 |
| Di Carlo, A | 1 |
| Delmonte, S | 1 |
| Hartgill, U | 1 |
| Jakopanec, I | 1 |
| Vestrheim, DF | 1 |
| Yuan, LF | 1 |
| Yin, YP | 1 |
| Pearline, RV | 1 |
| Xiang, Z | 1 |
| Desouza-Thomas, L | 1 |
| Maclure-Webster, E | 1 |
| Anderson, J | 1 |
| Nichols, T | 2 |
| Ferreira, CM | 1 |
| Naveca, FG | 1 |
| Almeida, NC | 1 |
| Vasconcelos, Wde S | 1 |
| Gomes, Jde S | 1 |
| Silva, Mde F | 1 |
| Alecrim, Md | 1 |
| Jayaraman, G | 1 |
| Liu, G | 1 |
| Gilmour, M | 1 |
| Hjelmevoll, SO | 1 |
| Olsen, ME | 1 |
| Sollid, JU | 1 |
| Haaheim, H | 1 |
| Melby, KK | 1 |
| Moi, H | 3 |
| Skogen, V | 1 |
| Pépin, J | 1 |
| Khonde, N | 1 |
| Dzokoto, A | 1 |
| Méda, H | 1 |
| Asamoah-Adu, C | 1 |
| Mayaud, P | 1 |
| Mabey, D | 1 |
| Demers, E | 1 |
| Goldstein, E | 1 |
| Reshef, D | 1 |
| Berman, S | 1 |
| Sabeti, P | 1 |
| Lipsitch, M | 1 |
| Vidovic, S | 1 |
| Anvari, V | 1 |
| Ballesteros, AM | 1 |
| Cruz, OM | 1 |
| Carbajal, JL | 1 |
| Chowdhry, S | 1 |
| Pandhi, D | 1 |
| Vidhani, S | 1 |
| Bhalla, P | 1 |
| Reddy, BS | 1 |
| Reunala, T | 1 |
| Hiltunen-Back, E | 1 |
| Burstein, GR | 1 |
| Berman, SM | 2 |
| Blumer, JL | 1 |
| Moran, JS | 3 |
| Moodley, P | 5 |
| Pillay, C | 2 |
| Nzimande, G | 1 |
| Coovadia, YM | 1 |
| Sturm, AW | 4 |
| Read, T | 1 |
| Mijch, A | 1 |
| Ostergaard, L | 1 |
| Trees, DL | 2 |
| Sirivongrangson, P | 1 |
| Schultz, AJ | 1 |
| Buatiang, A | 1 |
| Neal, SW | 5 |
| Knapp, JS | 9 |
| Kilmarx, PH | 2 |
| Martin, IM | 5 |
| Ng, LK | 2 |
| Martin, IE | 1 |
| Booth, S | 1 |
| Chaudhry, U | 1 |
| Ray, K | 4 |
| Saluja, D | 1 |
| Elawad, BB | 2 |
| Narayanan, M | 1 |
| Pattman, RS | 3 |
| Sankar, KN | 2 |
| Freeman, R | 1 |
| Dragsted, D | 1 |
| Lind, I | 2 |
| Sarwal, S | 1 |
| Sevigny, C | 1 |
| Balkhy, HH | 1 |
| Memish, ZA | 1 |
| Rich, M | 1 |
| Kumari, S | 2 |
| Wang, SA | 3 |
| Workowski, KA | 1 |
| Fenton, KA | 1 |
| Ison, C | 4 |
| Johnson, AP | 1 |
| Rudd, E | 1 |
| Soltani, M | 1 |
| Livermore, DM | 2 |
| Veitch, MG | 1 |
| Griffith, JM | 2 |
| Morgan, ML | 1 |
| Corkill, JE | 3 |
| Komolafe, AJ | 2 |
| Neal, TJ | 1 |
| Mortimore, A | 1 |
| Alawattegama, AB | 2 |
| Hart, CA | 4 |
| Ruiz, J | 1 |
| Marco, F | 1 |
| Sierra, JM | 1 |
| Aguilar, L | 1 |
| Garcia-Mendez, E | 1 |
| Mensa, J | 1 |
| Jiménez De Anta, MT | 1 |
| Vila, J | 1 |
| Sosa, J | 2 |
| Ramirez-Arcos, S | 1 |
| Ruben, M | 2 |
| Li, H | 2 |
| Llanes, R | 2 |
| Llop, A | 2 |
| Lee, MV | 2 |
| Ohye, RG | 2 |
| Whiticar, PM | 1 |
| Effler, PV | 1 |
| Liu, L | 1 |
| Tong, MH | 1 |
| Bakare, RA | 1 |
| Oni, AA | 1 |
| Umar, US | 1 |
| Kehinde, AO | 1 |
| Fayemiwo, SA | 1 |
| Alli, OO | 1 |
| Newell, A | 1 |
| Herbert, E | 1 |
| Vigus, J | 1 |
| Grieg, A | 1 |
| Rodgers, ME | 1 |
| Zheng, HP | 1 |
| Wu, XZ | 1 |
| Yang, LG | 1 |
| Wildt, S | 1 |
| Danielsen, AG | 1 |
| Friis-Møller, A | 1 |
| O'Mahony, C | 4 |
| Elks, R | 1 |
| Newman, LM | 1 |
| O'Connor, N | 1 |
| Sugunendran, H | 1 |
| Shigemura, K | 1 |
| Shirakawa, T | 1 |
| Okada, H | 1 |
| Hinata, N | 1 |
| Acharya, B | 1 |
| Kinoshita, S | 1 |
| Kofuku, T | 1 |
| Kawabata, M | 1 |
| Kamidono, S | 1 |
| Arakawa, S | 1 |
| Gotoh, A | 1 |
| Yoo, J | 1 |
| Yoo, C | 1 |
| Cho, Y | 1 |
| Park, H | 1 |
| Oh, HB | 2 |
| Seong, WK | 1 |
| Heffernan, H | 1 |
| Brokenshire, M | 1 |
| Woodhouse, R | 1 |
| MacCarthy, A | 1 |
| Blackmore, T | 1 |
| Giles, JA | 1 |
| Falconio, J | 1 |
| Yuenger, JD | 1 |
| Zenilman, JM | 1 |
| Bash, MC | 1 |
| Dewi, BE | 1 |
| Akira, S | 1 |
| Hayashi, H | 1 |
| Ba-Thein, W | 1 |
| Kim, TS | 1 |
| Choi, JR | 1 |
| Yum, JH | 1 |
| Shultz, T | 1 |
| Tapsall, JW | 5 |
| Moodley, D | 1 |
| Willem Sturm, A | 1 |
| Berglund, T | 1 |
| Colucci, B | 1 |
| Lund, B | 1 |
| Qvarnström, I | 1 |
| Sandström, E | 1 |
| Tanaka, M | 4 |
| Nakayama, H | 2 |
| Notomi, T | 1 |
| Irie, S | 1 |
| Tsunoda, Y | 1 |
| Okadome, A | 1 |
| Saika, T | 3 |
| Kobayashi, I | 3 |
| Zhou, W | 1 |
| Du, W | 2 |
| Cao, H | 1 |
| Zhao, J | 1 |
| Shen, Y | 1 |
| Zhang, S | 1 |
| Hsueh, PR | 1 |
| Tseng, SP | 1 |
| Teng, LJ | 1 |
| Ho, SW | 1 |
| Manavi, K | 1 |
| Young, H | 9 |
| McMillan, A | 3 |
| Kelly, C | 1 |
| Neal, T | 1 |
| Salhan, S | 1 |
| Ragunathan, PL | 1 |
| Roy, K | 1 |
| Meltzer, MI | 1 |
| Palmer, HM | 5 |
| Spratt, BG | 1 |
| Chaudhary, C | 1 |
| Hasan Chaudhary, FA | 1 |
| Pandy, AR | 1 |
| Karki, N | 1 |
| Kansaker, P | 1 |
| Das, AK | 1 |
| Ross, JL | 1 |
| Malla, S | 1 |
| Hossain, A | 1 |
| Neilsen, G | 1 |
| Rahman, M | 5 |
| Gharizadeh, B | 2 |
| Akhras, M | 2 |
| Wretlind, B | 2 |
| Nyrén, P | 1 |
| Pourmand, N | 2 |
| Herida, M | 1 |
| Desenclos, JC | 1 |
| Goulet, V | 1 |
| Laurent, E | 1 |
| Harry, TC | 1 |
| Nau, JY | 1 |
| Battikhi, MN | 1 |
| Ismail, H | 1 |
| Battikhi, Q | 1 |
| Pillay, K | 1 |
| Enders, M | 1 |
| Turnwald-Maschler, A | 1 |
| Sethi, S | 1 |
| Sharma, D | 1 |
| Mehta, SD | 1 |
| Singh, B | 1 |
| Smriti, M | 1 |
| Kumar, B | 1 |
| Sharma, M | 1 |
| McElhinney, J | 1 |
| Waters, L | 1 |
| Worthen, E | 1 |
| Gray, E | 1 |
| Morgan, J | 1 |
| Sutrisna, A | 1 |
| Soebjakto, O | 1 |
| Wignall, FS | 1 |
| Kaul, S | 1 |
| Limnios, EA | 2 |
| Ray, S | 2 |
| Nguyen, NL | 1 |
| Symes, RJ | 1 |
| Catt, CJ | 1 |
| Males, JJ | 1 |
| Sjöstrand, A | 1 |
| Lindbäck, E | 1 |
| Fredlund, H | 1 |
| Azariah, S | 1 |
| Perkins, N | 1 |
| Su, X | 3 |
| Jiang, F | 1 |
| Dai, X | 2 |
| Sun, H | 2 |
| Ye, S | 2 |
| Hovhannisyan, G | 1 |
| von Schoen-Angerer, T | 1 |
| Babayan, K | 1 |
| Fenichiu, O | 1 |
| Gaboulaud, V | 1 |
| Black, V | 1 |
| Magooa, P | 1 |
| Myers, M | 1 |
| Morris, AK | 1 |
| Hurst, DW | 1 |
| Thompson, MA | 1 |
| Hofmeister, EP | 1 |
| Brunel, AS | 1 |
| Fraisse, T | 1 |
| Lechiche, C | 1 |
| Sotto, A | 1 |
| Laporte, S | 1 |
| Le Lin, B | 1 |
| Pastore, R | 1 |
| Liassine, N | 1 |
| Aramburu, C | 1 |
| Sudre, P | 1 |
| Turner, A | 3 |
| Gough, KR | 2 |
| Jephcott, AE | 2 |
| McClean, AN | 2 |
| Patrick, D | 1 |
| Shaw, C | 1 |
| Rekart, ML | 1 |
| Pollock, LM | 1 |
| Randell, J | 1 |
| Wilson, P | 1 |
| Kopelman, PG | 1 |
| Washington, JA | 4 |
| Doyle, LJ | 3 |
| Parekh, MC | 2 |
| Rice, RJ | 2 |
| Ohye, R | 1 |
| Higa, H | 2 |
| Jain, SK | 1 |
| Kulkarni, MG | 2 |
| Banker, DD | 1 |
| Jiang, SC | 1 |
| Wang, XF | 1 |
| Miao, JZ | 1 |
| Forster, GE | 1 |
| Goh, BT | 1 |
| Loughlin, KA | 1 |
| Bakst, CM | 1 |
| Rybak, MJ | 1 |
| Kumazawa, J | 1 |
| Matsumoto, T | 1 |
| Jones, RB | 1 |
| Martin, DH | 1 |
| Bolan, GA | 1 |
| Mroczkowski, TF | 1 |
| Neumann, TM | 1 |
| Haag, JJ | 1 |
| Echols, R | 1 |
| Bodsworth, NJ | 1 |
| Price, R | 1 |
| Nelson, MJ | 1 |
| Gorwitz, RJ | 1 |
| Nakashima, AK | 1 |
| van Rijsoort-Vos, JH | 1 |
| Stolz, E | 3 |
| Verbrugh, HA | 1 |
| Kluytmans, JA | 1 |
| Morel, P | 2 |
| Gianotti, B | 2 |
| Barlow, D | 2 |
| Phillips, I | 3 |
| Jean, C | 2 |
| Thompson, C | 1 |
| Moyes, A | 3 |
| Barclay, LM | 1 |
| Forsyth, JR | 1 |
| Hogg, GG | 1 |
| Coughlan, EP | 1 |
| Franklin, RA | 1 |
| Aavitsland, P | 1 |
| Høiby, EA | 1 |
| Kam, KM | 1 |
| Wong, PW | 1 |
| Cheung, MM | 1 |
| Ho, NK | 1 |
| Gordon, SM | 1 |
| Carlyn, CJ | 1 |
| Knapp, CC | 1 |
| Longworth, DL | 1 |
| Hall, GS | 1 |
| Ringuette, L | 1 |
| Trudeau, T | 1 |
| Turcotte, P | 1 |
| Yeung, K | 1 |
| Rémis, R | 1 |
| Perron, L | 1 |
| Le Corre, I | 1 |
| Leow, YH | 1 |
| Chan, RK | 3 |
| Cheong, LL | 2 |
| Goh, CL | 1 |
| Nadarajah, M | 2 |
| Xia, M | 2 |
| Roberts, MC | 2 |
| Whittington, WL | 5 |
| Biedenbach, DJ | 2 |
| Jones, RN | 2 |
| Singh, G | 1 |
| Thomas, PD | 1 |
| Blackwell, AL | 1 |
| Thorpe, EM | 1 |
| Schwebke, JR | 1 |
| Rompalo, A | 1 |
| McCormack, WM | 2 |
| Mussari, KL | 1 |
| Giguere, GC | 1 |
| Collins, JJ | 1 |
| Fox, KK | 1 |
| Judson, FN | 1 |
| Thompson, SE | 1 |
| Gruber, F | 1 |
| Brajac, I | 1 |
| Jonjic, A | 1 |
| Grubisic-Greblo, H | 1 |
| Lenkovic, M | 1 |
| Stasic, A | 1 |
| Bakalova, LA | 2 |
| Akovbian, VA | 1 |
| Bednova, VN | 2 |
| Clutterbuck, DJ | 1 |
| Nissinen, A | 1 |
| Järvinen, H | 1 |
| Liimatainen, O | 1 |
| Jahkola, M | 1 |
| Huovinen, P | 1 |
| Brook, MG | 1 |
| Shafi, MS | 2 |
| St Louis, ME | 1 |
| Sayers, D | 1 |
| Mason, PR | 1 |
| Marowa, E | 1 |
| Katzenstein, DA | 1 |
| van de Laar, MJ | 1 |
| van Duynhoven, YT | 1 |
| Dessens, M | 1 |
| van Santen, M | 1 |
| van Klingeren, B | 1 |
| Ng, PP | 1 |
| Ling, AE | 1 |
| Shultz, TR | 3 |
| Bhuiyan, BU | 2 |
| Miah, RA | 1 |
| Rahman, KM | 2 |
| Albert, MJ | 3 |
| Rattan, A | 1 |
| Khanna, N | 1 |
| Pandhi, RK | 1 |
| Misra, RS | 1 |
| Aplasca, MR | 1 |
| Mesola, VP | 1 |
| Djajakusumah, T | 1 |
| Sudigdoadi, S | 1 |
| Keersmaekers, K | 1 |
| Meheus, A | 1 |
| Miah, MR | 1 |
| Nahar, S | 3 |
| Islam, N | 2 |
| Ahmed, M | 1 |
| Tayal, SC | 1 |
| Watson, PG | 2 |
| Galloway, A | 1 |
| Divekar, AA | 1 |
| Gogate, AS | 1 |
| Shivkar, LK | 1 |
| Divekar, A | 1 |
| Gogate, A | 1 |
| Noone, A | 1 |
| Bond, M | 1 |
| Butt, KD | 1 |
| Smith, CP | 1 |
| Haraoka, M | 1 |
| Wildman, G | 2 |
| Rajamanoharan, S | 2 |
| Tang, A | 1 |
| Pai, A | 1 |
| Koppikar, GV | 1 |
| Barfod, S | 1 |
| Tunoe, H | 1 |
| Mochida, O | 1 |
| Kanayama, A | 1 |
| Naito, S | 1 |
| Forsyth, A | 1 |
| Ivens, D | 2 |
| Fiorito, S | 1 |
| Pagano, I | 1 |
| Oviedo, C | 1 |
| Lanza, A | 1 |
| Smayevsky, J | 1 |
| Weltman, G | 1 |
| Buscemi, L | 1 |
| Sanjuán, E | 1 |
| David, N | 1 |
| Guzmán, D | 1 |
| Gutiérrez, Y | 1 |
| Ricardo, O | 1 |
| White, C | 1 |
| Alam, A | 2 |
| Nessa, K | 2 |
| Dutta, DK | 1 |
| Yasmin, L | 1 |
| Monira, S | 2 |
| Sultan, Z | 2 |
| Khan, SA | 1 |
| Philip, S | 1 |
| Greene, L | 1 |
| Aplasca De Los Reyes, MR | 1 |
| Pato-Mesola, V | 1 |
| Manalastas, R | 1 |
| Tuazon, CU | 1 |
| Dallabetta, G | 1 |
| Leeming, JP | 1 |
| Sandul, AL | 1 |
| Sealy, J | 1 |
| Prabhakar, P | 2 |
| Deshpande, L | 1 |
| Price, LM | 1 |
| Castor, D | 1 |
| Furlonge, C | 1 |
| Rao, A | 1 |
| Brown, A | 1 |
| Camara, B | 1 |
| Weiss, H | 1 |
| Jolly, PE | 1 |
| Nwokolo, NC | 1 |
| Boag, FC | 1 |
| Wang, Q | 1 |
| Rustomjee, R | 1 |
| Kharsany, AB | 1 |
| Connolly, CA | 1 |
| Karim, SS | 1 |
| Poch, F | 1 |
| Islam, S | 1 |
| Alam Khan, S | 1 |
| Bogaerts, J | 1 |
| Albert, J | 1 |
| Yagupsky, P | 1 |
| Schahar, A | 1 |
| Peled, N | 1 |
| Porat, N | 1 |
| Trefler, R | 1 |
| Keness, Y | 1 |
| Block, C | 1 |
| Phillips, EA | 1 |
| Timmins, D | 1 |
| Bugrov, AV | 1 |
| Navolotskaia, TI | 1 |
| Kisina, VI | 1 |
| Vakhnina, TE | 1 |
| Oduor, DO | 1 |
| Bwayo, JJ | 1 |
| Bhatt, SM | 1 |
| Kwasa, TO | 1 |
| Maitha, GM | 1 |
| Ombette, JO | 1 |
| Lovett, R | 1 |
| Munro, R | 1 |
| Saito, I | 1 |
| Suzuki, A | 1 |
| Yokozawa, M | 1 |
| Ono, K | 1 |
| Miyamura, R | 1 |
| Hamaya, O | 1 |
| Fuchs, PC | 1 |
| Barry, AL | 1 |
| Baker, C | 1 |
| Murray, PR | 1 |
| Miettinen, A | 1 |
| Laine, S | 1 |
| Teisala, K | 1 |
| Heinonen, PK | 1 |
| Bryan, JP | 1 |
| Hira, SK | 1 |
| Brady, W | 1 |
| Luo, N | 1 |
| Mwale, C | 1 |
| Mpoko, G | 1 |
| Krieg, R | 1 |
| Siwiwaliondo, E | 1 |
| Reichart, C | 1 |
| Waters, C | 1 |
| Melby, K | 1 |
| Faegri, A | 1 |
| Lassus, A | 2 |
| Karppinen, L | 1 |
| Ingervo, L | 1 |
| Jeskanen, L | 1 |
| Reitamo, S | 1 |
| Happonen, HP | 1 |
| Karkulahti, R | 1 |
| Smith, BL | 1 |
| Cummings, M | 1 |
| Benes, S | 1 |
| Draft, K | 1 |
| Orfanos, CE | 1 |
| Adler, M | 1 |
| Hörnle, R | 1 |
| Stadler, R | 1 |
| Shanmugaratnam, K | 1 |
| Sprott, MS | 1 |
| Kearns, AM | 1 |
| Coker, DM | 1 |
| Ahmed-Jushuf, I | 1 |
| Arya, OP | 3 |
| Chessbrough, JS | 1 |
| Pratt, BC | 3 |
| Loo, PS | 1 |
| Ridgway, GL | 1 |
| Oriel, JD | 2 |
| Tegelberg-Stassen, MJ | 1 |
| van der Hoek, JC | 1 |
| Mooi, L | 1 |
| Wagenvoort, JH | 2 |
| van Joost, T | 1 |
| Michel, MF | 1 |
| Shahmanesh, M | 1 |
| Shukla, SR | 1 |
| Westwood, A | 1 |
| Thin, RN | 1 |
| Hobson, D | 2 |
| Bartzokas, C | 1 |
| Ball, AP | 1 |
| Roddy, RE | 1 |
| Handsfield, HH | 1 |
| Okazaki, T | 1 |
| Kiyota, H | 1 |
| Gotoh, H | 1 |
| Boerema, JB | 1 |
| Moesker, HL | 1 |
| Van de Rhee, HJ | 1 |
| Renkonen, OV | 1 |
| Ellmén, J | 1 |
| Eugster, H | 1 |
| Eichmann, A | 1 |
| Ahmed-Jushuf, IH | 1 |
| How, SJ | 1 |
| Tait, IA | 1 |
| Rao, PM | 1 |
| van der Willigen, AH | 1 |
| Avonts, D | 1 |
| Fransen, L | 1 |
| Vielfont, J | 1 |
| Stevens, A | 1 |
| Hendrickx, K | 1 |
| Piot, P | 1 |
| Szarmach, H | 2 |
| Weuta, H | 2 |
| Podziewski, J | 2 |
| Skarzynski, J | 2 |
| Wronski, A | 2 |
| De Lalla, F | 1 |
| Rizzardini, G | 1 |
| Angelucci, B | 1 |
| Scott, GR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of SpeeDx's Ciprofloxacin gyrA Assay for Clinical Care of STD Clinic Patients With Neisseria Gonorrhea[NCT05286931] | 1,800 participants (Anticipated) | Interventional | 2022-03-03 | Recruiting | |||
| Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae[NCT02961751] | 211 participants (Actual) | Interventional | 2016-10-19 | Completed | |||
| Vaginal Self-sampling for Rapid Turnaround Gonorrhea/Chlamydia Testing in the Emergency Department[NCT03676816] | 533 participants (Actual) | Interventional | 2018-09-17 | Completed | |||
| Periodical Presumptive Treatment of Gonorrhoea in Female Sex Workers: Impact on Prevalence of the Disease in Sex Workers and Their Clients[NCT01329588] | Phase 4 | 636 participants (Actual) | Interventional | 2001-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Ciprofloxacin susceptibility was determined via culture-based antimicrobial susceptibility testing of the gonococcal isolate from each cervical sample with a positive N. gonorrhoeae culture at Visit 1. An infection was deemed susceptible to ciprofloxacin if the reported minimum inhibitory concentration for the isolate was < 1 mcg/ml. Detection of wild type gyrA was determined by the real-time PCR analysis of the gyrA gene from the swab taken at Visit 1. (NCT02961751)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Ciprofloxacin | 7 |
Ciprofloxacin susceptibility was determined via culture-based antimicrobial susceptibility testing of the gonococcal isolate from each pharyngeal sample with a positive N. gonorrhoeae culture at Visit 1. An infection was deemed susceptible to ciprofloxacin if the reported minimum inhibitory concentration for the isolate was < 1 mcg/ml. Detection of wild type gyrA was determined by the real-time PCR analysis of the gyrA gene from the swab taken at Visit 1. (NCT02961751)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Ciprofloxacin | 13 |
Ciprofloxacin susceptibility was determined via culture-based antimicrobial susceptibility testing of the gonococcal isolate from each rectal sample with a positive N. gonorrhoeae culture at Visit 1. An infection was deemed susceptible to ciprofloxacin if the reported minimum inhibitory concentration for the isolate was < 1 mcg/ml. Detection of wild type gyrA was determined by the real-time PCR analysis of the gyrA gene from the swab taken at Visit 1. (NCT02961751)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Ciprofloxacin | 60 |
Ciprofloxacin susceptibility was determined via culture-based antimicrobial susceptibility testing of the gonococcal isolate from each urethral sample with a positive N. gonorrhoeae culture at Visit 1. An infection was deemed susceptible to ciprofloxacin if the reported minimum inhibitory concentration for the isolate was < 1 mcg/ml. Detection of wild type gyrA was determined by the real-time PCR analysis of the gyrA gene from the swab taken at Visit 1. (NCT02961751)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Ciprofloxacin | 22 |
Subjects infected with gyrase A (gyrA) serine 91 genotype of Neisseria gonorrhoeae (N. gonorrhoeae) at the rectum were evaluated for microbiological cure at 5-10 days after treatment. Cure was defined as N. gonorrhoeae not detectable by culture from all anatomical sites that had detectable N. gonorrhoeae at baseline (NCT02961751)
Timeframe: Day 5 through Day 10
| Intervention | percentage of subjects (Number) |
|---|---|
| Ciprofloxacin | 100 |
Subjects infected with gyrase A (gyrA) serine 91 genotype of Neisseria gonorrhoeae (N. gonorrhoeae) at the throat were evaluated for microbiological cure at 5-10 days after treatment. Cure was defined as N. gonorrhoeae not detectable by culture from all anatomical sites that had detectable N. gonorrhoeae at baseline (NCT02961751)
Timeframe: Day 5 through Day 10
| Intervention | percentage of subjects (Number) |
|---|---|
| Ciprofloxacin | 100 |
Subjects infected with gyrase A (gyrA) serine 91 genotype of Neisseria gonorrhoeae (N. gonorrhoeae) at the urogenital tract were evaluated for microbiological cure at 5-10 days after treatment. Cure was defined as N. gonorrhoeae not detectable by culture from all anatomical sites that had detectable N. gonorrhoeae at baseline (NCT02961751)
Timeframe: Day 5 through Day 10
| Intervention | percentage of subjects (Number) |
|---|---|
| Ciprofloxacin | 100 |
Subjects infected with gyrase A (gyrA) serine 91 genotype of Neisseria gonorrhoeae (N. gonorrhoeae) were evaluated for microbiological cure at 5-10 days after treatment. Cure was defined as N. gonorrhoeae not detectable by culture from all anatomical sites that had detectable N. gonorrhoeae at baseline. (NCT02961751)
Timeframe: Day 5 through Day 10
| Intervention | percentage of subjects (Number) |
|---|---|
| Ciprofloxacin | 100 |
13 reviews available for ciprofloxacin and Neisseria gonorrhoeae Infection
| Article | Year |
|---|---|
Global epidemiology of antimicrobial resistance in commensal Neisseria species: A systematic review.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Mi | 2022 |
Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; beta-Lactams; Ciprofloxacin; DNA Gyrase; | 2022 |
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple | 2020 |
A Narrative Review of Clinical Treatment Outcomes of Neisseria gonorrhoeae Infection With Ciprofloxacin by Minimum Inhibitory Concentration and Anatomic Site.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gono | 2021 |
Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Gonorrhea; H | 2017 |
A 34-year-old man with urethral discharge.
Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Gonorrhea; Homosexuality, Male; | 2013 |
[Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Ne | 2013 |
[Changing epidemiological profile and treatment of syphilis and gonorrhea].
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Contact Tracing; Drug Resistance, | 2002 |
[Antibiotherapy applied to uncomplicated urethritis and cervicitis. French Agency for Health Product Safety].
Topics: Anti-Bacterial Agents; Asia; Chlamydia Infections; Ciprofloxacin; Drug Resistance, Multiple, Bacteri | 2006 |
Oral treatment of gonorrhea and chlamydia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Chlamydia Infections; Ciprofloxac | 1994 |
Emergence of high level ciprofloxacin resistant Neisseria gonorrhoeae strain in Buenos Aires, Argentina.
Topics: Adult; Anti-Infective Agents; Argentina; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Human | 2001 |
Overview of clinical experience with ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enteritis; Enterob | 1986 |
Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis.
Topics: 4-Quinolones; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia | 1986 |
25 trials available for ciprofloxacin and Neisseria gonorrhoeae Infection
| Article | Year |
|---|---|
Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2021 |
Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2021 |
Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2021 |
Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2021 |
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bact | 2021 |
Periodical antibiotic treatment for the control of gonococcal and chlamydial infections among sex workers in Benin and Ghana: a cluster-randomized placebo-controlled trial.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Benin; Chlamydia Infections; Ciprofloxacin; Cross-Sectio | 2012 |
Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Doxycycline; Drug Administra | 2002 |
[Clinical efficacy of ciprofloxacin and ofloxacin].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Dysentery, Bacillary; Female; Gonorrhe | 1994 |
Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.
Topics: Adolescent; Adult; Ceftriaxone; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Fe | 1993 |
Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Fluoroquinolones; G | 1995 |
Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double | 1996 |
Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; beta-Lactam | 1995 |
Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Cervix Uteri; Ciprofloxacin; F | 1996 |
Comparative trial of azithromycin and ciprofloxacin in the treatment of gonorrhea.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cul | 1997 |
A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefixime; Cephalosporins; Ciprofloxacin; Drug Resistance, | 2001 |
A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Ciprofloxacin; Doxycycline; Female; Follo | 2002 |
High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.
Topics: Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans | 2002 |
[Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
Topics: Chlamydia Infections; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female | 1992 |
Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia.
Topics: Adult; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Double-Blind Method; Drug Resistance, Micr | 1990 |
Ciprofloxacin versus amoxycillin and probenecid in the treatment of uncomplicated gonorrhoea.
Topics: Adolescent; Adult; Amoxicillin; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Drug Com | 1989 |
Evaluation of difloxacin in the treatment of uncomplicated urethral gonorrhea in men.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Ciprofloxacin; Clinical Trials as Topic; Fluoroq | 1989 |
Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Gonorrhea; Humans; Ma | 1986 |
Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.
Topics: Adolescent; Adult; Ampicillin; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clinical | 1986 |
Fleroxacin versus standard therapy in gonococcal urethritis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Follow-Up Studies; Gonorrhea; Humans; Male; | 1988 |
Ciprofloxacin treatment of chlamydial infections of urogenital tracts of women.
Topics: Chlamydia Infections; Ciprofloxacin; Clinical Trials as Topic; Female; Genital Diseases, Female; Gon | 1988 |
Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis | 1987 |
Oral ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in men.
Topics: Administration, Oral; Adolescent; Adult; Ciprofloxacin; Clinical Trials as Topic; Drug Evaluation; G | 1987 |
Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men.
Topics: Ampicillin; Ciprofloxacin; Gonorrhea; Humans; Infections; Male; Microbial Sensitivity Tests; Pharyng | 1987 |
335 other studies available for ciprofloxacin and Neisseria gonorrhoeae Infection
| Article | Year |
|---|---|
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Fluoroquinolon | 2008 |
Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages.
Topics: Anti-Bacterial Agents; Base Sequence; Cefixime; Cephalosporin Resistance; Chromosomes, Bacterial; Go | 2010 |
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporin | 2011 |
Antimicrobial Susceptibility of Urogenital and Extragenital Neisseria gonorrhoeae Isolates Among Men Who Have Sex With Men: Strengthening the US Response to Resistant Gonorrhea and Enhanced Gonococcal Isolate Surveillance Project, 2018 to 2019.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Homosexuality, Male; Hu | 2021 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacteri | 2021 |
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Gono | 2022 |
Dissemination and genome analysis of high-level ceftriaxone-resistant
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; | 2022 |
Molecular Surveillance and Prediction of Antimicrobial Resistance of Neisseria gonorrhoeae in Northern Alberta, Canada, 2015 to 2018.
Topics: Alberta; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacter | 2022 |
Genomic analyses of ciprofloxacin-resistant Neisseria gonorrhoeae isolates recovered from the largest South American metropolitan area.
Topics: Anti-Bacterial Agents; Brazil; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbi | 2022 |
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resista | 2022 |
Characterization of a Neisseria gonorrhoeae Ciprofloxacin panel for an antimicrobial resistant Isolate Bank.
Topics: Amino Acids; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Microbial | 2022 |
Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Gentamicins; Gonorrhea; Human | 2022 |
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteria | 2021 |
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Dr | 2022 |
Resistance-Guided Therapy for Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; | 2022 |
[The postal code as a "bar code" of antimicrobial resistance].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacteria | 2022 |
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteria | 2022 |
Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2022 |
Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Go | 2022 |
Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Cross-Sectional Stu | 2022 |
Australian Gonococcal Surveillance Programme Annual Report, 2021.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Neisseria gonorr | 2022 |
Trends and regional variations of gonococcal antimicrobial resistance in the Netherlands, 2013 to 2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; | 2022 |
Right hip gonococcal septic arthritis treatment with successful transition to oral fluoroquinolone.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, | 2022 |
Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2022 |
Assessing the National Representativeness of Estimates of Antimicrobial-Resistant Urogenital Neisseria gonorrhoeae in US Men, Gonococcal Isolate Surveillance Project, 2008-2018.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial | 2023 |
CanB is a metabolic mediator of antibiotic resistance in Neisseria gonorrhoeae.
Topics: Carbon Dioxide; Ciprofloxacin; Drug Resistance, Microbial; Genome-Wide Association Study; Gonorrhea; | 2023 |
Extra-genital
Topics: Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Female; Genitalia; Gonorrhea; Homosexuality, | 2023 |
Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacteria | 2023 |
Pre-exposure to azithromycin enhances gonococcal resilience to subsequent ciprofloxacin exposure: an
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; M | 2022 |
Pre-exposure to azithromycin enhances gonococcal resilience to subsequent ciprofloxacin exposure: an
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; M | 2022 |
Pre-exposure to azithromycin enhances gonococcal resilience to subsequent ciprofloxacin exposure: an
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; M | 2022 |
Pre-exposure to azithromycin enhances gonococcal resilience to subsequent ciprofloxacin exposure: an
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; M | 2022 |
Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Gonorrhea; Humans; Neisseria gonorrhoeae | 2023 |
Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteria | 2023 |
Rapid Molecular Phenotypic Antimicrobial Susceptibility Test for
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial | 2023 |
Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016-2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrh | 2023 |
Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets - Authors' reply.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gonorrhea; Humans; Neisseria gonorrhoeae | 2023 |
Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gonorrhea; Humans; Neisseria gonorrhoeae | 2023 |
Sanguinarine, similar to the MICs of spectinomycin, exhibits good anti-Neisseria gonorrhoeae activity in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrh | 2023 |
Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis.
Topics: Anti-Infective Agents; Australia; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Neisseria gonorrhoe | 2023 |
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Genomics; Gonorrhea; | 2023 |
Antimicrobial susceptibilities and genomic epidemiology of Neisseria gonorrhoeae in Stockholm, Sweden.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Genomic | 2023 |
Peptide barcode of multidrug-resistant strains of Neisseria gonorrhoeae isolated from patients in Thailand.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2023 |
Correlates of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Cross-Sectional St | 2023 |
Development of Cas13a-based assays for
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; HIV Infections; Humans; | 2023 |
Australian Gonococcal Surveillance Programme Annual Report, 2022.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multipl | 2023 |
Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; | 2023 |
Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of
Topics: Agar; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; | 2023 |
Agent-based modelling study of antimicrobial-resistant Neisseria gonorrhoeae transmission in men who have sex with men: towards individualised diagnosis and treatment.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Homosexual | 2019 |
Addressing Neisseria gonorrhoeae Treatment Resistance With the DNA Gyrase A Assay: An Economic Study, United States.
Topics: Anti-Bacterial Agents; Asymptomatic Infections; Ciprofloxacin; Clinical Laboratory Techniques; Cohor | 2020 |
Susceptibility patterns in
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorr | 2019 |
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; European U | 2019 |
Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Prescriptions; Drug Resistance, Bacter | 2020 |
Australian Gonococcal Surveillance Programme Annual Report, 2018.
Topics: Anti-Bacterial Agents; Australia; Australian Capital Territory; Ciprofloxacin; Gonorrhea; Humans; Mi | 2020 |
Sharp increase in ciprofloxacin resistance of
Topics: Adult; Anti-Bacterial Agents; Cameroon; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea | 2020 |
Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Demography; Drug Resistance, Bac | 2020 |
Australian Gonococcal Surveillance Programme Annual Report, 2019.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteri | 2020 |
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteria | 2020 |
High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; | 2020 |
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacteri | 2020 |
Antibiotic-Sparing Gonorrhea Diagnostic Wins Federal Funding.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrh | 2020 |
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Gonorrhea; H | 2021 |
Pain in the eye: a case of gonococcal orbital cellulitis.
Topics: Adult; Cefixime; Ciprofloxacin; Female; Gonorrhea; Humans; Neisseria gonorrhoeae; Orbital Cellulitis | 2021 |
Australian Gonococcal Surveillance Programme 1 July to 30 September 2020.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteri | 2020 |
Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx).
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteriological Techniques; Ciprofloxacin; Drug Resi | 2021 |
Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrh | 2021 |
Reflex Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of the SpeeDx ResistancePlus GC Assay.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensi | 2021 |
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteria | 2021 |
Developing a model to predict individualised treatment for gonorrhoea: a modelling study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; England | 2021 |
Demographic and Behavioral Risk Factors Associated with Reduced Susceptibility of Neisseria gonorrhoeae to First-Line Antimicrobials in South African Men with Gonococcal Urethral Discharge.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gono | 2021 |
Molecular characterization of a ceftriaxone-resistant Neisseria gonorrhoeae strain found in Switzerland: a case report.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Gonorr | 2021 |
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multi | 2021 |
WGS to predict antibiotic MICs for Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; En | 2017 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
.
Topics: Annual Reports as Topic; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; | 2017 |
A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Dr | 2017 |
Antimicrobial susceptibility in
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Disk D | 2018 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; beta-Lactamases; Cephalosporins; China; Cip | 2017 |
Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Contact Tra | 2017 |
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Resista | 2017 |
Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ceftriaxone; China; Ciprofloxacin; Drug Res | 2018 |
Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Primers; Gonorrhea; Humans; Microbial Sensitiv | 2017 |
Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance | 2017 |
Epidemiology of Neisseria gonorrhoeae Gyrase A Genotype, Los Angeles, California, USA.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Fem | 2017 |
Phase variation of DNA methyltransferases and the regulation of virulence and immune evasion in the pathogenic Neisseria.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ceftazidime; Ciprofloxacin; DNA Methylatio | 2017 |
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin R | 2017 |
Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Disease Transmission, Infectious; D | 2017 |
Antimicrobial susceptibility profile of
Topics: Anti-Bacterial Agents; Benin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fema | 2018 |
High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, P | 2018 |
Exploring quinolone resistance-determining region in
Topics: Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gonorrhea; Humans; Indi | 2017 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Vientiane, Lao PDR.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Chi | 2018 |
A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
Topics: Anti-Bacterial Agents; Azithromycin; California; Ceftriaxone; Ciprofloxacin; Costs and Cost Analysis | 2018 |
A Comparison of Real-Time Polymerase Chain Reaction Assays for the Detection of Antimicrobial Resistance Markers and Sequence Typing From Clinical Nucleic Acid Amplification Test Samples and Matched Neisseria gonorrhoeae Culture.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cephalosporins; Ciprofloxacin; Dru | 2018 |
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cervix | 2018 |
Ciprofloxacin May be Efficacious in Treating Wild-Type Gyrase A Genotype Neisseria gonorrhoeae Infections.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Gonorrhea; H | 2018 |
First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Brazil; Ceftriaxone; Ciprofloxacin; Drug Resistance, Mul | 2018 |
Quality assurance for antimicrobial susceptibility testing of
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Disk Diffusion An | 2018 |
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; | 2018 |
Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, | 2018 |
Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Data Accuracy; Disk Diffusion Antimicrobial Tests; Gonorrhea; | 2018 |
The Frequency of Discordant Gyrase A Genotypes Among Cases of Multiple Neisseria gonorrhoeae Infections at Different Anatomic Sites.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Ge | 2019 |
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Yaoundé, Cameroon From 2009 to 2014.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cameroon; Ciprofloxacin; Drug Resistance, Multiple, Bact | 2018 |
Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; HIV Infections; | 2019 |
Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014-2017.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cote d'Ivoire; Drug Resistanc | 2019 |
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxo | 2018 |
Comparison of Neisseria gonorrhoeae minimum inhibitory concentrations obtained using agar dilution versus microbroth dilution methods.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Culture Me | 2019 |
A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacteria | 2019 |
Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Female; Genotype; Geno | 2019 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2018
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multipl | 2019 |
[From surveillance to action: Modifying therapeutic behaviours in gonococcal infections].
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofl | 2020 |
Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Genotype; | 2019 |
Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Genotyping T | 2019 |
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance | 2013 |
Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; | 2013 |
Low prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Nuuk, Greenland.
Topics: Adult; Anti-Bacterial Agents; Cells, Cultured; Cervix Uteri; Ciprofloxacin; Drug Resistance, Microbi | 2013 |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; beta-Lactam Resistance; Cefixime; Ceftriax | 2013 |
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxo | 2013 |
Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, | 2014 |
Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; | 2014 |
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child | 2014 |
High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cervix Uteri; Ciprofloxacin; Drug Resistance | 2014 |
Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Cities; Drug Resistance, Microbial; Gonorrh | 2014 |
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Typing Techniques; Ce | 2014 |
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Ceftriaxo | 2014 |
Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanning, China, 2000 to 2012.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Azithromycin; beta-Lactamases; Ceftriaxone; China; C | 2014 |
Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Ci | 2014 |
[Resistance to ciprofloxacin of Neisseria gonorrhoeae strains isolated in Poland in 2012-2013].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Contraindications; Drug Resistance, Microbial; Gonorrhea; Huma | 2014 |
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; E | 2014 |
Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Ciprofl | 2016 |
Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated from Guangzhou, China, 2000 to 2005 and 2008 to 2013.
Topics: Anti-Bacterial Agents; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorr | 2015 |
Can previous first-line therapies for Neisseria gonorrhoeae be targeted to specific patient subgroups to treat gonorrhea?
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; Engla | 2015 |
Twenty-five-year changing pattern of gonococcal antimicrobial susceptibility in Shanghai: surveillance and its impact on treatment guidelines.
Topics: Anti-Bacterial Agents; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gono | 2014 |
Fluoroquinolone resistance in Neisseria gonorrhoeae after cessation of ciprofloxacin usage in San Francisco: using molecular typing to investigate strain turnover.
Topics: Adult; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Mal | 2015 |
Australian gonococcal surveillance programme, 1 April to 30 June 2014.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Disease Notification; Dr | 2014 |
Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gonorrh | 2015 |
Prevalence of gonococcal conjunctivitis in adults and neonates.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Conjunctivit | 2015 |
Rapid change in the ciprofloxacin resistance pattern among Neisseria gonorrhoeae strains in Nuuk, Greenland: time to reconsider preventive and treatment strategies.
Topics: Adult; Ciprofloxacin; Cohort Studies; Cold Climate; Drug Resistance, Microbial; Female; Gonorrhea; G | 2015 |
Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained From Women and Men.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Heterose | 2015 |
Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens.
Topics: Anti-Bacterial Agents; Canada; Ciprofloxacin; Cross Reactions; DNA Gyrase; DNA Topoisomerase IV; Dru | 2015 |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resi | 2016 |
An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.
Topics: Adult; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Disease Outbreaks; DNA | 2016 |
Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Ge | 2016 |
Temocillin in vitro activity against recent clinical isolates of Neisseria gonorrhoeae compared with penicillin, ceftriaxone and ciprofloxacin.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; N | 2016 |
Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multipl | 2015 |
Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Genitalia; Gonorrhea; Huma | 2016 |
Increasing Incidence of High-Level Tetracycline-Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign Import.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacter | 2016 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resist | 2016 |
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; M | 2016 |
Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015).
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Gonorrhea; | 2016 |
Rapid spread of Neisseria gonorrhoeae ciprofloxacin resistance due to a newly introduced resistant strain in Nuuk, Greenland, 2012-2015: a community-based prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea | 2016 |
Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciproflox | 2016 |
Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
Topics: Adult; Alleles; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriax | 2016 |
Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.
Topics: Anti-Bacterial Agents; Australia; Ciprofloxacin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; G | 2016 |
Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes.
Topics: Anti-Bacterial Agents; Australia; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multi | 2017 |
Codon 91 Gyrase A Testing Is Necessary and Sufficient to Predict Ciprofloxacin Susceptibility in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Codon; Fluoroquinolones; Genomics; Gonorrhea; | 2017 |
Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Utilization; Female; Genotyping | 2017 |
Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Drug Resistance, | 2017 |
Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cervix Uteri; Chi-Square Distribution; China; C | 2017 |
Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial | 2008 |
Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam.
Topics: Adult; Anti-Bacterial Agents; Cameroon; Ceftriaxone; Central African Republic; Ciprofloxacin; Drug R | 2008 |
Neisseria gonorrhoeae meningitis in pregnant adolescent.
Topics: Adolescent; Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; DNA Primers; Drug Resistance, Multi | 2008 |
[Ciprofloxacin resistance of Neisseria gonorrhoeae according to sexual habits].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Argentina; Ciprofloxacin; Drug Resistance, Bacterial | 2008 |
Increasing trend in gonococcal resistance to ciprofloxacin in The Netherlands, 2006-8.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorr | 2010 |
Antimicrobial resistance in gonorrhea: the influence of epidemiologic and laboratory surveillance data on treatment guidelines: Alberta, Canada 2001-2007.
Topics: Adult; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Neisser | 2009 |
Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteri | 2009 |
Resistance trends in Neisseria gonorrhoeae in southwestern Ohio.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; H | 2010 |
Trends in antimicrobial susceptibility of Neisseria gonorrhoeae in Israel, 2002 to 2007, with special reference to fluoroquinolone resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; F | 2010 |
Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA | 2010 |
[Gonorrhea--time for new guidelines].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; F | 2011 |
Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; | 2011 |
Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefixime; Ciprofloxacin; Drug Resistance, Multiple, | 2011 |
Genotyping of two Neisseria gonorrhoeae fluroquinolone-resistant strains in the Brazilian Amazon Region.
Topics: Adult; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Gonorrhea | 2011 |
Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Canada; Child; Child, Preschool; | 2011 |
Appropriate time for test-of-cure when diagnosing gonorrhoea with a nucleic acid amplification test.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefixime; Cervix Uteri; Ciprofloxacin; Drug Resistan | 2012 |
Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality | 2012 |
Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada, 2005 to 2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cluster Analysis; DNA, Bacterial; Drug Resistanc | 2012 |
Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriax
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Drug Resistance, | 2012 |
High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi.
Topics: Anti-Infective Agents; Ciprofloxacin; Gonorrhea; Humans; Incidence; Male; Microbial Sensitivity Test | 2002 |
Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: does the benefit outweigh the risk?
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Gonorrhea; Humans; Risk Assessment | 2002 |
Gonococcal perianal abscess: re-emergence after cessation of co-trimoxazole.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; | 2002 |
Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999.
Topics: Anti-Infective Agents; Ciprofloxacin; Clone Cells; Drug Resistance, Bacterial; Gonorrhea; Humans; In | 2002 |
Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Typing Techni | 2002 |
Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.
Topics: Anti-Infective Agents; Canada; Ciprofloxacin; DNA Gyrase; DNA Probes; DNA Topoisomerase IV; Drug Res | 2002 |
Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; | 2002 |
What is new with antibiotic-resistant gonorrhoea in Newcastle, England?
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Typing Techni | 2002 |
Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Nuuk, Greenland during 1998-1999.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Child; Ciprofloxacin; Drug Resistance, Microbial; Fe | 2002 |
Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.
Topics: Anti-Infective Agents; Canada; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisser | 2003 |
Antibiotic susceptibility of Neisseria gonorrhoeae in Riyadh, Saudi Arabia.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbi | 2003 |
Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India.
Topics: Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; In | 2003 |
Fluoroquinolones, gonorrhea, and the CDC STD treatment guidelines.
Topics: Anti-Infective Agents; Centers for Disease Control and Prevention, U.S.; Ciprofloxacin; Drug Resista | 2003 |
Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; England; Female; Gonorrhea; Humans | 2003 |
Ciprofloxacin resistance emerges in Neisseria gonorrhoeae in Victoria, 1998 to 2001.
Topics: Adult; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrh | 2003 |
Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Prot | 2003 |
In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistan | 2003 |
High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Cuba; Female; Genotype; Gonorrhea; | 2003 |
Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Hawaii; Humans; Neisser | 2003 |
[Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Chronic Disease; Ciprofloxacin; Erythromycin; Go | 2003 |
Non-penicillinase producing Neisseria gonnorhoeae: are they still in existence in Ibadan, Nigeria?
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Anti-Infective Agents; Case-Control Stud | 2001 |
Gonorrhoea in a south London genitourinary medicine department.
Topics: Adolescent; Adult; Age Distribution; Aged; Amoxicillin; Anti-Infective Agents; Black or African Amer | 2003 |
Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; D | 2003 |
[Diagnosis and treatment of gonorrhea in Copenhagen and Frederiksberg].
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Denmark; Drug Resistance, Multiple, Bacterial; Go | 2003 |
Gonorrhoea, test of cure, evidence-based medicine and the Emperor's new clothes!
Topics: Anti-Infective Agents; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Evidenc | 2004 |
The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, B | 2004 |
Gonorrhoea: test of cure for sensitive bacteria? Use of genotyping to disprove treatment failure.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Gonorrhe | 2004 |
Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; | 2004 |
Antimicrobial resistance patterns (1999-2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; | 2004 |
Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Asia; Child; Child, Preschool; Ciproflox | 2004 |
Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; Disease Outbreaks; DNA Gyrase; DNA Topoisomeras | 2004 |
High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Res | 2004 |
Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries.
Topics: Amino Acid Substitution; Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Mutational Analysis; | 2004 |
Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.
Topics: Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Hum | 2004 |
[Increasing incidence of ciprofloxacin resistant gonorrhea in Sweden. Choose a correct antibiotic and follow up the treatment!].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gonorrh | 2004 |
Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
Topics: Amino Acid Substitution; Anti-Infective Agents; Arginine; Ciprofloxacin; DNA Gyrase; DNA Topoisomera | 2004 |
Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.
Topics: Anti-Infective Agents; China; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bact | 2004 |
High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Northern Taiwan.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Humans; | 2005 |
The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Female; Gonorrhea; Humans; Male; Medical Audit; M | 2005 |
The rise and fall of ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonor | 2005 |
First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fema | 2005 |
Nalidixic acid-susceptible, ciprofloxacin-resistant Neisseria gonorrhoeae strain in the UK.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; M | 2005 |
Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Computer Simulation; | 2005 |
Ciprofloxacin-resistant gonorrhoea in South Africa.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria | 2005 |
The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Genotype; Gonorrhea; Human | 2005 |
A pilot study on antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Nepal.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Female; | 2005 |
Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Codon; DNA Gyrase; DNA Mutational Analysis | 2005 |
Increase of Neisseria gonorrhoeae ciprofloxacin resistance in France in 2001-2003.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Child; Ciprofloxacin; Drug Resistance, Bacterial; Fe | 2006 |
RE: Ciprofloxacin resistance in Great Yarmouth and Waveney district.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; England; Female | 2006 |
[Gonococcus: the disturbing development of strains resistant to ciprofloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonor | 2006 |
Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Ciprofloxaci | 2006 |
Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial | 2006 |
Dramatic increase in a single genotype of TRNG ciprofloxacin-resistant Neisseria gonorrhoeae isolates in men who have sex with men.
Topics: Anti-Infective Agents; Bacterial Typing Techniques; Ciprofloxacin; Drug Resistance, Bacterial; Engla | 2006 |
Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance; Female; Germ | 2006 |
Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; India; Male; Mi | 2006 |
Extended surveillance of gonorrhoea in Scotland 2003.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care Facilities; Anti-Bacterial Agents; Anti-Infective Ag | 2006 |
Rectal microscopy in men - expensive, time consuming and inappropriate.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistan | 2006 |
Increasing ciprofloxacin resistance in gonorrhoea.
Topics: Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; New Zealand | 2006 |
Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004 - implications for treatment.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Indonesia; Micr | 2006 |
Diffuse lamellar keratitis associated with gonococcal keratoconjunctivitis 3 years after laser in situ keratomileusis.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Corneal Stroma; Doxycycline; Drug Therapy, | 2007 |
Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Mandatory Reporting; Microbial Sensiti | 2007 |
Risk factors and characteristics of patients with gonorrhoea presenting to Auckland Sexual Health Service, New Zealand.
Topics: Adolescent; Adult; Age Distribution; Anti-Infective Agents; Case-Control Studies; Cervix Uteri; Cipr | 2007 |
Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; China; Ciprofloxacin; Drug Resistance | 2007 |
Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
Topics: Anti-Bacterial Agents; Armenia; Ciprofloxacin; Doxycycline; Gonorrhea; Humans; Kanamycin; Microbial | 2007 |
The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa's syndromic management approach be revised?
Topics: Ceftriaxone; Ciprofloxacin; Counseling; Drug Resistance, Microbial; Gonorrhea; HIV Infections; Human | 2008 |
Opa-typing can identify epidemiologically distinct subgroups within Neisseria gonorrhoeae multi-antigen sequence type (NG-MAST) clusters.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Typing Techniques; Ciprofloxacin; DNA Primers; | 2008 |
Atypical presentation of soft-tissue mass with gonococcal infection in the hand.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Gonorrhea; Humans; Magnetic Resonance Imaging; Male; Ne | 2008 |
[A sexually transmitted peritonitis].
Topics: Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Female; Gonorrhea; Humans; Middle Aged; Perit | 2008 |
A new sexually transmitted infection (STI) in Geneva? Ciprofloxacin-resistant Neisseria gonorrhoeae, 2002-2005.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; | 2008 |
Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gono | 1995 |
Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon.
Topics: Anti-Infective Agents; British Columbia; Ciprofloxacin; Contact Tracing; Dose-Response Relationship, | 1995 |
Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Ne | 1995 |
Acute gonococcal arthritis: an unusual host and pathogen combination.
Topics: Acute Disease; Aged; Arthritis, Infectious; Ciprofloxacin; Gonorrhea; Humans; Knee Joint; Male; Neis | 1995 |
Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.
Topics: beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Microbial Sensi | 1994 |
Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Microbial Sensitivity Tests; N | 1994 |
Antibiotic susceptibility pattern of gonococcal isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria | 1994 |
Ciprofloxacin resistant gonococci arriving from Thailand.
Topics: Adult; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Ur | 1994 |
Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Male; M | 1994 |
From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Male; M | 1994 |
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
Topics: Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Microbi | 1994 |
A case of gonococcal mastitis in a male.
Topics: Adult; Ciprofloxacin; Floxacillin; Gonorrhea; Homosexuality; Humans; Male; Mastitis; Neisseria gonor | 1993 |
Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group.
Topics: Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria gonorrhoe | 1993 |
In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gonorrh | 1995 |
Ciprofloxacin resistant Neisseria gonorrhoeae.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Humans; | 1995 |
High-level ciprofloxacin-resistant Neisseria gonorrhoeae and heterosexually acquired infections in Victoria.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Male; N | 1996 |
Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial | 1996 |
[Treatment of uncomplicated gonorrhea in adults. New guidelines from the working group against gonorrhea].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Gonorrhea; Humans; Male; | 1996 |
Detection of quinolone-resistant Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Fleroxacin; Fluo | 1996 |
The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors.
Topics: Anti-Infective Agents; Case-Control Studies; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Geno | 1996 |
Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Humans; | 1996 |
Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin: pulsed-field gel electrophoresis typing of strains from North America, Hawaii, and the Philippines.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Ge | 1996 |
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration.
Topics: Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Evaluation Studies as Topic; Gon | 1996 |
An audit of the problems in management of patients with gonorrhoea.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Bacteriological Te | 1997 |
Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gono | 1997 |
[Ciprofloxacin in the treatment of urogenital infections in women].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chlamydia Infections; Chronic Disease; Ciprofloxacin | 1997 |
Anaphylactoid reaction to ciprofloxacin.
Topics: Adult; Anaphylaxis; Anti-Infective Agents; Ciprofloxacin; Gonorrhea; Humans; Male; Microbial Sensiti | 1997 |
Antimicrobial resistance in Neisseria gonorrhoeae in Finland, 1976 to 1995. The Finnish Study Group For Antimicrobial Resistance.
Topics: Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity | 1997 |
High level ciprofloxacin resistant gonorrhoea imported from Russia.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Ru | 1997 |
Intercity spread of gonococci with decreased susceptibility to fluoroquinolones: a unique focus in the United States.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Electrophor | 1998 |
Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; Ciprofloxacin; Drug Resistance | 1997 |
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Re | 1997 |
Gonorrhoea treatment failure and ciprofloxacin resistance.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Neisseria gonor | 1998 |
Continuing evolution of the pattern of quinolone resistance in Neisseria gonorrhoeae isolated in Sydney, Australia.
Topics: Anti-Infective Agents; Australia; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Huma | 1998 |
Neisseria gonorrhoeae resistant to ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Neisseria gonor | 1998 |
High prevalence of ciprofloxacin resistance amongst strains of Neisseria gonorrhoeae isolated from commercial sex workers in Bangladesh.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Microbial; | 1998 |
Emergence of fluoroquinolone resistant Neisseria gonorrhoeae in New Delhi, India.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; India | 1998 |
Correlates of gonococcal infection and of antimicrobial-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Condoms; Drug Resistance, Microbial; Female; Gonorrhea; | 1999 |
Evaluation of syndromic patient management algorithm for urethral discharge.
Topics: Administration, Oral; Adolescent; Adult; Algorithms; Bacteriological Techniques; Chlamydia Infection | 1998 |
Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin.
Topics: Anti-Infective Agents; Bangladesh; Ciprofloxacin; Disease Reservoirs; Drug Resistance, Microbial; Ep | 1999 |
Neisseria gonorrhoeae in Newcastle upon Tyne 1995-1997: increase in ciprofloxacin resistance.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; England; Female; Gonorrhea; | 1999 |
Association between auxotypes, serogroups, and antibiotic susceptibilities of Neisseria gonorrhoeae isolated from women in Mumbai (formerly Bombay), India.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; Ciprofloxacin; Female; Go | 1999 |
Ciprofloxacin resistance in Neisseria gonorrhoeae isolated in Mumbai (formerly Bombay), India.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; India; Prevalen | 1999 |
Epidemiology and treatment outcome of infection with antibiotic resistant strains of Neisseria gonorrhoeae in Scotland.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Female; Gonorrhe | 1999 |
A one-year survey of gonococcal infection seen in the genitourinary medicine department of a London district general hospital.
Topics: Adolescent; Adult; Animals; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Female; Gono | 1999 |
National guideline for the management of gonorrhoea in adults. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Contact Tracing; Female; Gonorrhea; Humans; | 1999 |
Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.
Topics: Amino Acid Substitution; Amino Acids; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing | 2000 |
Ciprofloxacin-resistant gonorrhoea.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male | 2000 |
Antibiotics sensitivity pattern of N. gonorrhoeae with special emphasis on norfloxacin and ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Gonorrhea; Humans; Ma | 1999 |
[Impossible treatment of gonorrhea].
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Denmark; Drug Costs; Gonorrhea; H | 2000 |
Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Microbia | 2000 |
Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Fluo | 2000 |
Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
Topics: Anti-Infective Agents; Ciprofloxacin; Denmark; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, | 2001 |
Increased ciprofloxacin resistance in gonococci isolated in Scotland.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Male; N | 2000 |
Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a first-line therapy?
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Community Health Centers; Drug Resist | 2000 |
From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Microbia | 2000 |
Ciprofloxacin 250 mg for treating gonococcal urethritis and cervicitis.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrh | 2000 |
Neisseria gonorrhoeae resistant to ciprofloxacin: first report in Cuba.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cuba; Drug Resistance, Microbial; Gonorrhea; Humans; Ma | 2001 |
Would you get your Gonorrhoea treated in the north of England?
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; England; Female; Gonorrhea; Guideline Adher | 2001 |
Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh.
Topics: Adult; Anti-Infective Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrh | 2001 |
Ciprofloxacin resistance in gonococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Neisseria gonor | 2001 |
Investigation of an outbreak of ciprofloxacin-resistant Neisseria gonorrhoeae using a simplified opa-typing method.
Topics: Antigens, Bacterial; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Pol | 2001 |
Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Microbi | 2001 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxac | 2001 |
Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gonorr | 2001 |
Gonococcal ophthalmia treated with ciprofloxacin.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Infective Agents; Ciprofloxacin; Endophth | 2001 |
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; | 2001 |
Antibiotic-resistant gonorrhoea in a London GUM clinic.
Topics: Adult; Ambulatory Care Facilities; Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Drug Resistanc | 2002 |
Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998.
Topics: Adult; Anti-Bacterial Agents; Cervix Uteri; China; Ciprofloxacin; Community Health Centers; Drug Res | 2002 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Bacterial; | 2002 |
Increasing incidence of gonorrhea in Israel associated with countrywide dissemination of a ciprofloxacin-resistant strain.
Topics: Adult; Bacterial Typing Techniques; Ciprofloxacin; Drug Resistance, Bacterial; Electrophoresis, Gel, | 2002 |
Gonorrhoea in London: usefulness of first line therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, B | 2002 |
Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics.
Topics: Anti-Bacterial Agents; Australia; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, | 1992 |
Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].
Topics: 4-Quinolones; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Ad | 1992 |
Treatment failure using double dose ciprofloxacin in a case of highly resistant gonorrhoea.
Topics: Adult; Ciprofloxacin; Drug Administration Schedule; Gonorrhea; Humans; Male; Treatment Outcome | 1992 |
Multiple sexually acquired diseases occurring concurrently in an HIV positive man: case report, diagnosis and management.
Topics: Adult; Anti-Infective Agents; Chancroid; Ciprofloxacin; Condylomata Acuminata; Gonorrhea; HIV Seropo | 1992 |
Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Urethritis | 1992 |
[Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Drug Evaluation; Drug Resistance, Micr | 1991 |
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; In Vitro Techniques; Microbial Sensiti | 1991 |
The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease.
Topics: Adult; Bacteriological Techniques; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Doxyc | 1991 |
The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
Topics: Ampicillin; Ampicillin Resistance; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Gonorrhea | 1989 |
[Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain].
Topics: Adolescent; Adult; Cefotaxime; Ciprofloxacin; Epididymitis; Female; Gonorrhea; Humans; Male; Neisser | 1989 |
Single dose ciprofloxacin to treat women with gonorrhoea.
Topics: Ciprofloxacin; Female; Gonorrhea; Humans | 1989 |
Evaluation of single dose ciprofloxacin in the treatment of rectal and pharyngeal gonorrhoea.
Topics: Ciprofloxacin; Drug Administration Schedule; Female; Gonorrhea; Humans; Male; Pharyngeal Diseases; R | 1989 |
Single dose ciprofloxacin for treating gonococcal infections in men.
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Gonorrhea; Humans; Male; Pharyngitis; Pr | 1985 |
Ciprofloxacin for treating urethral gonorrhoea in men.
Topics: Ciprofloxacin; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillinase; Quinolines; Urethritis | 1986 |
Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men.
Topics: Adult; Chlamydia Infections; Ciprofloxacin; Drug Evaluation; Gonorrhea; Humans; Male; Quinolines; Ur | 1986 |
[Bacteriological and clinical study of ciprofloxacin in gonococcal urethritis].
Topics: Administration, Oral; Adult; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Mid | 1986 |
Fleroxacin (Ro 23-6240) in the treatment of gonorrhoea.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Gonorrhea; Humans; Male | 1988 |
Single dose therapy with Ro 23-6240 in patients suffering from acute, non-complicated gonococcal infection.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Gonorrhea; Humans; Male | 1987 |
Treating uncomplicated gonococcal infection with 250 mg or 100 mg ciprofloxacin in a single oral dose.
Topics: Administration, Oral; Ciprofloxacin; Female; Gonorrhea; Humans; Male | 1988 |
Efficacy of a new quinolone in acute male gonorrhea.
Topics: Acute Disease; Ciprofloxacin; Gonorrhea; Humans; Male | 1987 |
Ciprofloxacin in acute male gonorrhea.
Topics: Acute Disease; Adult; Ciprofloxacin; Gonorrhea; Humans; Male | 1986 |